<SEC-DOCUMENT>0001493152-22-023422.txt : 20220818
<SEC-HEADER>0001493152-22-023422.hdr.sgml : 20220818
<ACCEPTANCE-DATETIME>20220818111832
ACCESSION NUMBER:		0001493152-22-023422
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20220818
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220818
DATE AS OF CHANGE:		20220818

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Save Foods Inc.
		CENTRAL INDEX KEY:			0001789192
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				264684680
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40403
		FILM NUMBER:		221176648

	BUSINESS ADDRESS:	
		STREET 1:		156 FIFTH AVENUE 10TH FLOOR
		STREET 2:		CO EARTHBOUND LLC
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010-7751
		BUSINESS PHONE:		972544561349

	MAIL ADDRESS:	
		STREET 1:		156 FIFTH AVENUE 10TH FLOOR
		STREET 2:		CO EARTHBOUND LLC
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010-7751
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:SVFD="http://savefoods.co/20220818">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_SVFD_savefoods.co_20220818 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20220818_20220818 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001789192 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:EntityCentralIndexKey">0001789192</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="svfd-20220818.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-08-18to2022-08-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001789192</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-18</xbrli:startDate>
        <xbrli:endDate>2022-08-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; margin-top: 0pt; font-size: 1pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_906_edei--DocumentType_c20220818__20220818_zehzVU1XzG66"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT PURSUANT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
SECTION 13 OR 15(D) OF THE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
EXCHANGE ACT OF 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_90C_edei--DocumentPeriodEndDate_c20220818__20220818_z6zQ5dgY3gkf"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 18,
2022</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(August 15, 2022)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_90C_edei--EntityRegistrantName_c20220818__20220818_ziI72WYIWvth"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:EntityRegistrantName">SAVE
FOODS, INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20220818__20220818_z2PNUmxYUDHe"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
or other jurisdiction of incorporation)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityFileNumber_c20220818__20220818_zyCSw372vTPc"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:EntityFileNumber">001-40403</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20220818__20220818_ztToeKNRFT86"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:EntityTaxIdentificationNumber">26-4684680</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_900_edei--EntityAddressAddressLine1_c20220818__20220818_zaqEBPNTO2Xf"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:EntityAddressAddressLine1">HaPardes
134 (Meshek Sander)</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_90B_edei--EntityAddressCityOrTown_c20220818__20220818_zYh2ZJIu6Jfg"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:EntityAddressCityOrTown">Neve
Yarak</ix:nonNumeric></span>, <span><span id="xdx_90B_edei--EntityAddressCountry_c20220818__20220818_zZdyLrPcT452"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Israel</ix:nonNumeric></span></span>,<span id="xdx_909_edei--EntityAddressPostalZipCode_c20220818__20220818_zfBtez9L25e4"> <ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:EntityAddressPostalZipCode">4994500</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices) (Zip Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tel: </b></span><b><span id="xdx_906_edei--CityAreaCode_c20220818__20220818_z7FskrlvJJ76"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:CityAreaCode">(347)</ix:nonNumeric></span></b><b> <span id="xdx_90E_edei--LocalPhoneNumber_c20220818__20220818_zIrKD8fEgX5d"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:LocalPhoneNumber">468
9583</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
Name or Former Address, if Changed Since Last Report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--WrittenCommunications_c20220818__20220818_zxo8EIa3CMi2"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SolicitingMaterial_c20220818__20220818_zgEtQJ1ZAnQ6"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementTenderOffer_c20220818__20220818_z3CRGAjPm1I4"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementIssuerTenderOffer_c20220818__20220818_zianck9ZDvn9"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20220818__20220818_zvAKjYhkXwV5"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:Security12bTitle">Common
                                            Stock, Par value</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.0001
    per share</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20220818__20220818_zT2dWRwb4Aog"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" name="dei:TradingSymbol">SVFD</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span><span>The
    <span id="xdx_900_edei--SecurityExchangeName_c20220818__20220818_z0jLKS6gYZf1"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market LLC</span></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20220818__20220818_z0kSZcBvKN3e"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90C_edei--EntityExTransitionPeriod_c20220818__20220818_zt9258EcOEz1"><ix:nonNumeric contextRef="From2022-08-18to2022-08-18" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; margin-top: 0pt; font-size: 1pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 15, 2022, Save Foods, Inc. (the &#8220;Company&#8217;), entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;),
with ThinkEquity LLC, as representative (the &#8220;Representative&#8221;), of the several underwriters named therein (the &#8220;Underwriters&#8221;),
relating to the Company&#8217;s public offering (the &#8220;Offering&#8221;) of 1,600,000 shares (the &#8220;Shares&#8221;) of the Company&#8217;s
common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), at a purchase price of $3.00 per share. Pursuant to the Underwriting
Agreement, the Company granted the Underwriters a 45-day option to purchase up to 240,000 additional shares of Common Stock less the
underwriting discounts and commissions solely to cover over-allotments. The expected closing date of the Offering is August
18, 2022 (the &#8220;Closing Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares were offered, issued and sold under a prospectus supplement filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
on August 17, 2022, in connection with a takedown from the Company&#8217;s shelf registration statement on Form S-3 (Registration No.
333-266159), which became effective on July 22, 2022. In connection with the Offering, the Company agreed to issue to the Representative
a warrant (the &#8220;Representative Warrant&#8221;) to purchase up to 5% of the shares of Common Stock sold in the Offering. The Representative
Warrant is exercisable, in whole or in part, at a per share exercise price of $3.75, which is equal to 125% of the public offering price
per share of Common Stock. The Representative Warrant will be exercisable commencing on the date which is one hundred eighty (180) days
following August 15, 2022 and will expire on August 15, 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriting Agreement contained customary representations, warranties and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended,
other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting
Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such
agreement and were subject to limitations agreed upon by the contracting parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
officers and directors of the Company and certain of its stockholders have agreed, subject to certain exceptions, not to offer, issue,
sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any shares of the Company&#8217;s Common Stock
or other securities convertible into or exercisable or exchangeable for shares of its Common Stock for either (i) a period of six months
for the Company&#8217; officers and directors, or (ii) a period of three months for those certain of the Company&#8217;s stockholders
after the date of the final prospectus filed in connection with the Offering without the prior written consent of the Underwriters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriting Agreement is filed as Exhibit 1.1 hereto and is incorporated herein by reference. The form of the Representative Warrant
is filed as Exhibit 4.1 hereto and is incorporated herein by reference. The foregoing descriptions of the terms of the Underwriting Agreement
and Representative Warrant are qualified in their entirety by reference to such exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01 Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 15, 2022, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is attached as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></p>
                                                                     <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No.</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Underwriting Agreement, between ThinkEquity, a division of Fordham Financial Management, Inc., as representative of the several underwriters, and Save Foods, Inc.</span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Form of Representative Warrant</span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of McDermott Will &amp; Emery LLP</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of McDermott, Will &amp; Emery LLP (included in Exhibit 5.1)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated August 15, 2022</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SAVE FOODS, INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    David Palach</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Palach</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    August 18, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVEKwkAMRE/QO4T9Fm1XFOmfFhWxihQRf1ebymK7Kdlt1SN5S9cWMQRCmHkzQgzEmla6RIbzIkvhiFVdKoeQYYGM5orekWy2Mfib4U1bx8q47v2BCXkGPTMZRpOLFzprqy3mMYSzUTQbSQnhNB5LmO9E8NUTMoXO0TitSlAmhwNTzRqd4lefcFRPMlS9uqoTstVkYoiGYS+/QYaRhD216kF8t5CmiQgG3QRizdTU35rGOqpgWWLlu2yP/jf4ABWvSUQ= -->

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNDERWRITING
AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">between</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Save
foods, inc.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ThinkEquity
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
Representative of the Several Underwriters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>UNDERWRITING
AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
15, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Representative of the several Underwriters named on <U>Schedule 1</U> attached hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 41<SUP>st</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Save Foods, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates,
including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries
or affiliates of Save Foods, Inc., the &#8220;<B>Company</B>&#8221;), hereby confirms its agreement (this &#8220;<B>Agreement</B>&#8221;)
with ThinkEquity LLC (hereinafter referred to as &#8220;you&#8221; (including its correlatives) or the &#8220;<B>Representative</B>&#8221;
or &#8220;<B>ThinkEquity</B>&#8221;), and with the other underwriters named on <U>Schedule 1</U> hereto for which the Representative
is acting as representative (the Representative and such other underwriters being collectively called the &#8220;<B>Underwriters</B>&#8221;
or, individually, an &#8220;<B>Underwriter</B>&#8221;) as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.<U>Purchase
and Sale of Shares.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Firm Shares.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.1
<U>Nature and Purchase of Firm Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 103.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) On the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the
Company agrees to issue and sell to the several Underwriters, an aggregate of 1,600,000 shares (the &#8220;<B>Firm Shares</B>&#8221;)
of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;<B>Common Stock</B>&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Underwriters, severally and not jointly, agree to purchase from the Company the number of Firm Shares set forth opposite their respective
names on <U>Schedule 1</U> attached hereto and made a part hereof at a purchase price of $2.79 per Firm Share (93% of the per Firm Share
offering price). The Firm Shares are to be offered initially to the public at the offering price set forth on the cover page of the Prospectus
(as defined in Section 2.1.1 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.2
<U>Firm Shares Payment and Delivery.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 135.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Delivery and payment for the Firm Shares shall be made at 10:00 a.m., Eastern time, on the second (2<SUP>nd</SUP>) Business Day following
the effective date (the &#8220;<B>Effective Date</B>&#8221;) of the Registration Statement (as defined in Section 2.1.1 below) pursuant
to Rule 430B(f)(2) of the Securities Act of 1933, as amended (the &#8220;<B>Securities Act</B>&#8221;) (or the third (3<SUP>rd</SUP>)
Business Day following the Effective Date if the pricing for the Offering (as defined in Section 2.1.1 below) occurs after 4:01 p.m.,
Eastern time on the Effective Date), or at such earlier time as shall be agreed upon by the Representative and the Company, at the offices
of Blank Rome LLP, 1271 Avenue of the Americas, New York, New York 10020 (&#8220;<B>Representative Counsel</B>&#8221;), or at such other
place (or remotely by facsimile or other electronic transmission) as shall be agreed upon by the Representative and the Company. The
hour and date of delivery and payment for the Firm Shares is called the &#8220;<B>Closing Date</B>.&#8221;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Payment for the Firm Shares shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order of the
Company upon delivery of the certificates (in form and substance satisfactory to the Underwriters) representing the Firm Shares (or through
the facilities of the Depository Trust Company (&#8220;<B>DTC</B>&#8221;)) for the account of the Representative. The Firm Shares shall
be registered in such name or names and in such authorized denominations as the Representative may request in writing at least two (2)
full Business Days prior to the Closing Date. The Company shall not be obligated to sell or deliver the Firm Shares except upon tender
of payment by the Representative for all of the Firm Shares. The term &#8220;<B>Business Day</B>&#8221; means any day other than a Saturday,
a Sunday or a legal holiday or a day on which banking institutions are authorized or obligated by law to close in New York, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<U>Over-allotment Option.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.1
<U>Option Shares</U>. For the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Shares,
the Company hereby grants to the Representative an option to purchase up to 240,000 additional shares of Common Stock, representing fifteen
percent (15%) of the Firm Shares sold in the offering, from the Company (the &#8220;<B>Over-allotment Option</B>&#8221;). Such 240,000
additional shares of Common Stock, the net proceeds of which will be deposited with the Company&#8217;s account, are hereinafter referred
to as the &#8220;<B>Option Shares</B>.&#8221; The purchase price to be paid per Option Share shall be equal to the price per Firm Share
set forth in Section 1.1.1 hereof. The Firm Shares and the Option Shares are hereinafter referred to together as the &#8220;<B>Public
Securities</B>.&#8221; The offering and sale of the Public Securities is hereinafter referred to as the &#8220;<B>Offering</B>.&#8221;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.2
<U>Exercise of the Over-allotment Option.</U> The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by
the Representative as to all (at any time) or any part (from time to time) of the Option Shares within 45 days after the date of the
Prospectus (as defined below). The Underwriters shall not be under any obligation to purchase any Option Shares prior to the exercise
of the Over-allotment Option. The Over-allotment Option granted hereby may be exercised by the giving of oral notice to the Company from
the Representative, which must be confirmed in writing by overnight mail or facsimile or other electronic transmission setting forth
the number of Option Shares to be purchased and the date and time for delivery of and payment for the Option Shares (the &#8220;<B>Option
Closing Date</B>&#8221;), which shall not be later than one (1) full Business Day after the date of the notice or such other time as
shall be agreed upon by the Company and the Representative, at the offices of Representative Counsel or at such other place (including
remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and the Representative. If such delivery
and payment for the Option Shares does not occur on the Closing Date, the Option Closing Date will be as set forth in the notice. Upon
exercise of the Over-allotment Option with respect to all or any portion of the Option Shares, subject to the terms and conditions set
forth herein, (i) the Company shall become obligated to sell to the Underwriters the number of Option Shares specified in such notice
and (ii) each of the Underwriters, acting severally and not jointly, shall purchase that portion of the total number of Option Shares
then being purchased as set forth in <U>Schedule 1</U> opposite the name of such Underwriter bears to the total number of Firm Shares,
subject, in each case, to such adjustments as the Representative, in its sole discretion, shall determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.3
<U>Payment and Delivery</U>. Payment for the Option Shares shall be made on the Option Closing Date by wire transfer in Federal (same
day) funds, payable to the order of the Company upon delivery to you of certificates (in form and substance satisfactory to the Representative)
representing the Option Shares (or through the facilities of DTC) for the account of the Underwriters. The Option Shares shall be registered
in such name or names and in such authorized denominations as the Representative may request in writing at least one (1) full Business
Day prior to the Option Closing Date. The Company shall not be obligated to sell or deliver the Option Shares except upon tender of payment
by the Representative for applicable Option Shares. The Option Closing Date may be simultaneous with, but not earlier than, the Closing
Date; and in the event that such time and date are simultaneous with the Closing Date, the term &#8220;<B>Closing Date</B>&#8221; shall
refer to the time and date of delivery of the Firm Shares and Option Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<U>Representative&#8217;s Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.1
<U>Purchase Warrants</U>. The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date
and Option Closing Date, as applicable, an option (&#8220;<B>Representative&#8217;s Warrant</B>&#8221;) for the purchase of an aggregate
number of shares of Common Stock representing 5% of the Public Securities purchased on such Closing Date or Option Closing Date, for
an aggregate purchase price of $100.00. The Representative&#8217;s Warrant agreement, in the form attached hereto as <U>Exhibit A</U>
(the &#8220;<B>Representative&#8217;s Warrant Agreement</B>&#8221;), shall be exercisable, in whole or in part, commencing on a date
which is one hundred eighty (180) days immediately following the commencement of the sales of the Common Stock in this offering and expiring
on the five-year anniversary of the commencement of sales of the securities issued in this offering at an initial exercise price per
share of Common Stock of $3.75, which is equal to 125% of the initial public offering price of the Firm Shares. The Representative&#8217;s
Warrant Agreement and the shares of Common Stock issuable upon exercise thereof are hereinafter referred to together as the &#8220;<B>Representative&#8217;s
Securities</B>.&#8221; The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110
against transferring the Representative&#8217;s Warrant Agreement and the underlying shares of Common Stock during the one hundred eighty
(180) days immediately following the commencement of the sales of the Common Stock in this offering and by its acceptance thereof shall
agree that it will not sell, transfer, assign, pledge or hypothecate the Representative&#8217;s Warrant Agreement, or any portion thereof,
or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition
of such securities for a period of one hundred eighty (180) days immediately following the commencement of the sales of the Common Stock
in this offering to anyone other than (i) an Underwriter or a selected dealer in connection with the Offering, or (ii) an officer, partner,
registered person or affiliate of the Representative or of any such Underwriter or selected dealer; and only if any such transferee agrees
to the foregoing lock-up restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.2
<U>Delivery</U>. Delivery of the Representative&#8217;s Warrant shall be made on the Closing Date and any Option Closing Date and shall
be issued in the name or names and in such authorized denominations as the Representative may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations and Warranties of the Company</U>.
The Company represents and warrants to the Underwriters as of the Applicable Time (as defined below), as of the Closing Date and as of
the Option Closing Date, if any, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Filing of Registration Statement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1
<U>Pursuant to the Securities Act</U>. The Company has filed with the U.S. Securities and Exchange Commission (the &#8220;<B>Commission</B>&#8221;)
a &#8220;shelf&#8221; registration statement on Form S-3 (File No. 333-266159), including any related prospectus or prospectuses, for
the registration of the Public Securities under the Securities Act, which registration statement was prepared by the Company in all material
respects in conformity with the requirements of the Securities Act and the rules and regulations of the Commission under the Securities
Act (the &#8220;<B>Securities Act Regulations</B>&#8221;) and contains and will contain all material statements that are required to
be stated therein in accordance with the Securities Act and the Securities Act Regulations. Except as the context may otherwise require,
such registration statement on file with the Commission at any given time, including any amendments thereto to such time, exhibits and
schedules thereto at such time, documents filed as a part thereof or incorporated pursuant to Item 12 of Form S-3 under the Securities
Act at such time and the documents and information otherwise deemed to be a part thereof or included therein pursuant to Rule 430B of
the Securities Act Regulations (the &#8220;<B>Rule 430B Information</B>&#8221;) or otherwise pursuant to the Securities Act Regulations
at such time, is referred to herein as the &#8220;<B>Registration Statement</B>.&#8221; The Registration Statement at the time it originally
became effective is referred to herein as the &#8220;<B>Initial Registration Statement</B>.&#8221; If the Company files any registration
statement pursuant to Rule 462(b) of the Securities Act Regulations, then after such filing, the term &#8220;Registration Statement&#8221;
shall include such registration statement filed pursuant to Rule 462(b). The Registration Statement was declared effective by the Commission
on July 22, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
prospectus in the form in which it was filed with the Commission in connection with the Initial Registration Statement is herein called
the &#8220;<B>Base Prospectus</B>.&#8221; Each preliminary prospectus supplement to the Base Prospectus (including the Base Prospectus
as so supplemented) that described the Public Securities and the Offering and omitted the Rule 430B Information and that was used prior
to the filing of the final prospectus supplement referred to in the following paragraph is herein called a &#8220;<B>Preliminary Prospectus</B>.&#8221;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly
after the execution and delivery of this Agreement, the Company will prepare and file with the Commission a final prospectus supplement
to the Base Prospectus relating to the Public Securities and the Offering in accordance with the provisions of Rule 430B and Rule 424(b)
of the Securities Act Regulations. Such final prospectus supplement (including the Base Prospectus as so supplemented), in the form filed
with the Commission pursuant to Rule 424(b) under the Securities Act is herein called the &#8220;<B>Prospectus</B>.&#8221; Any reference
herein to the Base Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated
by reference therein pursuant to Item 12 of Form S-3 under the Securities Act as of the date of such prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<B>Applicable
Time</B>&#8221; means 8:00 p.m., Eastern time, on the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<B>Disclosure
Package</B>&#8221; means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Preliminary Prospectus
dated August 15, 2022 and the information included on <U>Schedule 2-A</U> hereto, all considered together.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<B>Issuer
Free Writing Prospectus</B>&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 of the Securities Act
Regulations (&#8220;<B>Rule 433</B>&#8221;), including without limitation any &#8220;free writing prospectus&#8221; (as defined in Rule
405 of the Securities Act Regulations) relating to the Public Securities that is (i) required to be filed with the Commission by the
Company, (ii) a &#8220;road show that is a written communication&#8221; within the meaning of Rule 433(d)(8)(i), whether or not required
to be filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a
description of the Public Securities or of the Offering that does not reflect the final terms, in each case in the form filed or required
to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule
433(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<B>Issuer
General Use Free Writing Prospectus</B>&#8221; means any Issuer Free Writing Prospectus that is intended for general distribution to
prospective investors (other than a &#8220;<I>bona fide</I> electronic road show,&#8221; as defined in Rule 433), as evidenced by its
being specified in <U>Schedule 2-B</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<B>Issuer
Limited Use Free Writing Prospectus</B>&#8221; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing
Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2
<U>Pursuant to the Exchange Act</U>. The Company has filed with the Commission a Form 8-A (Accession No. 001-40403) providing for the
registration pursuant to Section 12(b) under the Securities Exchange Act of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;),
of the shares of Common Stock. The registration of the shares of Common Stock and related Form 8-A have become effective under the Exchange
Act on or prior to the date hereof. The Company has taken no action designed to, or likely to have the effect of, terminating the registration
of the shares of Common Stock under the Exchange Act, nor has the Company received any notification that the Commission is contemplating
terminating such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Stock Exchange Listing</U>. The shares of Common Stock and the shares of Common Stock underlying the Representative&#8217;s Warrants
have been approved for listing on The NASDAQ Capital Market (the &#8220;<B>Exchange</B>&#8221;), and the Company has taken no action
designed to, or likely to have the effect of, delisting the shares of Common Stock or the shares of Common Stock underlying the Representative&#8217;s
Warrants from the Exchange, nor has the Company received any notification that the Exchange is contemplating terminating such listing
except as described in the Registration Statement, the Disclosure Package and the Prospectus. The Company has submitted the Listing of
Additional Shares Notification Form with the Exchange with respect to the Offering of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>No Stop Orders, etc.</U> Neither the Commission nor, to the Company&#8217;s knowledge, any state regulatory authority has issued any
order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has instituted
or, to the Company&#8217;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied
with each request (if any) from the Commission for additional information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4
<U>Disclosures in Registration Statement.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.1
<U>Compliance with Securities Act and 10b-5 Representation.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.7pt; text-align: justify; text-indent: 103.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective (including each deemed effective
date with respect to the Underwriters pursuant to Rule 430B or otherwise under the Securities Act) complied and will comply in all material
respects with the requirements of the Securities Act and the Securities Act Regulations. The conditions for use of Form S-3, set forth
in the General Instructions thereto, including, but not limited to, General Instruction I.B.6 and other conditions related to the offer
and sale of the Public Securities, have been satisfied. Each Preliminary Prospectus and the Prospectus, at the time each was or will
be filed with the Commission, complied and will comply in all material respects with the requirements of the Securities Act and the Securities
Act Regulations. Each Preliminary Prospectus delivered to the Underwriters for use in connection with this Offering and the Prospectus
was or will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the
extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Neither the Registration Statement nor any amendment thereto, at its effective time, as of the Applicable Time, at the Closing Date or
at any Option Closing Date (if any), contained, contains or will contain an untrue statement of a material fact or omitted, omits or
will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Disclosure Package, as of the Applicable Time, at the Closing Date or at any Option Closing Date (if any), did not, does not and
will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; and any Issuer Limited Use Free Writing Prospectus hereto
does not conflict with the information contained in the Registration Statement, any Preliminary Prospectus or the Prospectus, and each
such Issuer Limited Use Free Writing Prospectus, as supplemented by and taken together with the Prospectus as of the Applicable Time,
did not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading; <I>provided</I>, <I>however</I>, that this representation and
warranty shall not apply to statements made or statements omitted in reliance upon and in conformity with written information furnished
to the Company with respect to the Underwriters by the Representative expressly for use in the Registration Statement, the Disclosure
Package or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree that such information provided
by or on behalf of any Underwriter consists solely of the following statements concerning the Underwriters contained in the &#8220;Underwriting&#8221;
section of the Prospectus (the &#8220;<B>Underwriters Information</B>&#8221;): (i) the first paragraph of the subsection entitled &#8220;Discounts
and Commissions; Expenses&#8221; related to concessions; (ii) the third paragraph under the subsection entitled &#8220;Price Stabilization,
Short Positions and Penalty Bids&#8221;; and (iii) the subsection entitled &#8220;Electronic Distribution.&#8221;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time
of any filing with the Commission pursuant to Rule 424(b), at the Closing Date or at any Option Closing Date, included, includes or will
include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided</I>, <I>however</I>, that
this representation and warranty shall not apply to the Underwriters&#8217; Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
The documents incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, when they became effective
or were filed with the Commission, as the case may be, conformed in all material respects to the requirements of the Securities Act or
the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder and none of such documents contained any
untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated
by reference in the Registration Statement, the Disclosure Package and the Prospectus, when such documents become effective or are filed
with the Commission, as the case may be, will conform in all material respects to the requirements of the Securities Act or the Exchange
Act, as applicable, and the rules and regulations of the Commission thereunder, and will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.2
<U>Disclosure of Agreements</U>. The agreements and documents described in the Registration Statement, the Disclosure Package and the
Prospectus conform in all material respects to the descriptions thereof contained or incorporated by reference therein and there are
no agreements or other documents required by the Securities Act and the Securities Act Regulations to be described in the Registration
Statement, the Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, or
to be incorporated by reference in the Registration Statement, the Disclosure Package or the Prospectus, that have not been so described
or filed or incorporated by reference. Each agreement or other instrument (however characterized or described) to which the Company or
its Subsidiary (as defined below) is a party or by which it is or may be bound or affected and (i) that is referred to or incorporated
by reference in the Registration Statement, the Disclosure Package and the Prospectus, or (ii) is material to the Company&#8217;s or
its Subsidiary&#8217;s business, has been duly authorized and validly executed by the Company, is in full force and effect in all material
respects and is enforceable against the Company and, to the Company&#8217;s knowledge, the other parties thereto, in accordance with
its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&#8217;
rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities
laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable
defenses and to the discretion of the court before which any proceeding therefor may be brought. None of such agreements or instruments
has been assigned by the Company or its Subsidiary, and none of the Company, its Subsidiary nor, to the Company&#8217;s knowledge, any
other party is in default thereunder and, to the best of the Company&#8217;s knowledge, no event has occurred that, with the lapse of
time or the giving of notice, or both, would constitute a default thereunder. To the best of the Company&#8217;s knowledge, performance
by the Company or its Subsidiary of the material provisions of such agreements or instruments will not result in a violation of any existing
applicable law, rule, regulation, ordinance, judgment, order or decree of any governmental or regulatory agency, body, authority or court,
domestic or foreign, having jurisdiction over the Company or its Subsidiary or any of its assets or businesses (each, a &#8220;<B>Governmental
Entity</B>&#8221;), including, without limitation, those relating to environmental laws and regulations. The Company owns or controls,
directly or indirectly, only Save Foods, Ltd. (the &#8220;<B>Subsidiary</B>&#8221;) and has no other interest, nominal or beneficial,
direct or indirect, in any other corporation, joint venture or other business entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.3
<U>Prior Securities Transactions</U>. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit
of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed in the Registration
Statement, the Disclosure Package and the Preliminary Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.4
<U>Regulations</U>. The disclosures in the Registration Statement, the Disclosure Package and the Prospectus concerning the effects of
federal, state, local and all foreign regulation on the Offering and the Company&#8217;s business as currently contemplated are accurate,
correct and complete in all material respects and no other such regulations are required to be disclosed in the Registration Statement,
the Disclosure Package and the Prospectus which are not so disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.5
<U>No Other Distribution of Offering Materials.</U> The Company has not, directly or indirectly, distributed and will not distribute
any offering material in connection with the Offering other than any Preliminary Prospectus, the Disclosure Package, the Prospectus and
other materials, if any, permitted under the Securities Act and consistent with Section 3.2 below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5
<U>Changes After Dates in Registration Statement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.1.
<U>No Material Adverse Change</U>. Since the respective dates as of which information is given in the Registration Statement, the Disclosure
Package and the Prospectus, except as otherwise specifically stated therein: (i) there has been no material adverse change in the financial
position or results of operations of the Company, nor any change or development that, singularly or in the aggregate, would involve a
material adverse change or a prospective material adverse change, in or affecting the condition (financial or otherwise), results of
operations, business, assets or prospects of the Company or the Subsidiary (a &#8220;<B>Material Adverse Change</B>&#8221;); (ii) there
have been no material transactions entered into by the Company, other than as contemplated pursuant to this Agreement; (iii) no officer
or director of the Company has resigned from any position with the Company; and (iv) neither the Company nor its Subsidiary has sustained
any material loss or interference with its business or properties from fire, explosion, flood, earthquake, hurricane, accident or other
calamity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.2.
<U>Recent Securities Transactions, etc</U>. Subsequent to the respective dates as of which information is given in the Registration Statement,
the Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the Registration
Statement, the Disclosure Package and the Prospectus, the Company has not: (i) issued any securities or incurred any liability or obligation,
direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other distribution on or in respect to its
capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6
<U>Disclosures in Commission Filings</U>. Since January 1, 2021, (i) none of the Company&#8217;s filings with the Commission contained
any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; and (ii) the Company has made all filings with the Commission
required under the Exchange Act and the rules and regulations of the Commission promulgated thereunder (the &#8220;<B>Exchange Act Regulations</B>&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7
<U>Independent Accountants</U>. To the knowledge of the Company, each of KPMG International and Halperin Ilanit, Certified Public Accountants
(Israel) (the &#8220;<B>Auditors</B>&#8221;), whose respective reports are filed with the Commission and included or incorporated by
reference in the Registration Statement, the Disclosure Package and the Prospectus, is each an independent registered public accounting
firm as required by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board. The Auditors
have not, during the periods covered by the financial statements included or incorporated by reference in the Registration Statement,
the Disclosure Package and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of
the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8
<U>Financial Statements, etc</U>. The financial statements, including the notes thereto and supporting schedules included or incorporated
by reference in the Registration Statement, the Disclosure Package and the Prospectus, fairly present the financial position and the
results of operations of the Company at the dates and for the periods to which they apply; and such financial statements have been prepared
in conformity with U.S. generally accepted accounting principles (&#8220;<B>GAAP</B>&#8221;), consistently applied throughout the periods
involved (provided that unaudited interim financial statements are subject to year-end audit adjustments that are not expected to be
material in the aggregate and do not contain all footnotes required by GAAP); and the supporting schedules included or incorporated by
reference in the Registration Statement present fairly the information required to be stated therein. No other historical or pro forma
financial statements or supporting schedules are required to be included in the Registration Statement, the Disclosure Package or the
Prospectus by the Securities Act or the Securities Act Regulations. The pro forma financial statements and the related notes, if any,
included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus have been properly compiled
and prepared in accordance with the applicable requirements of the Securities Act, the Securities Act Regulations, the Exchange Act or
the Exchange Act Regulations and present fairly the information shown therein, and the assumptions used in the preparation thereof are
reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred to therein.
All disclosures contained in the Registration Statement, the Disclosure Package or the Prospectus, or incorporated or deemed incorporated
by reference therein, regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and regulations of the
Commission), if any, comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent
applicable. Each of the Registration Statement, the Disclosure Package and the Prospectus discloses all material off-balance sheet transactions,
arrangements, obligations (including contingent obligations), and other relationships of the Company with unconsolidated entities or
other persons that may have a material current or future effect on the Company&#8217;s financial condition, changes in financial condition,
results of operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses. Except
as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, (a) neither the Company nor any of its direct
and indirect subsidiaries, including each entity disclosed or described in the Registration Statement, the Disclosure Package and the
Prospectus as being a subsidiary of the Company (each, a &#8220;<B>Subsidiary</B>&#8221; and, collectively, the &#8220;<B>Subsidiaries</B>&#8221;),
has incurred any material liabilities or obligations, direct or contingent, or entered into any material transactions other than in the
ordinary course of business, (b) the Company has not declared or paid any dividends or made any distribution of any kind with respect
to its capital stock, (c) there has not been any change in the capital stock of the Company or any of its Subsidiaries, or, other than
in the course of business or any grants under any stock compensation plan, and (d) there has not been any Material Adverse Change in
the Company&#8217;s long-term or short-term debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9
<U>Authorized Capital; Options, etc</U>. The Company had, at the date or dates indicated in the Registration Statement, the Disclosure
Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions
stated in the Registration Statement, the Disclosure Package and the Prospectus, the Company will have on the Closing Date the adjusted
stock capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Disclosure Package,
the Prospectus and the SEC Reports, on the date hereof, as of the Applicable Time and on the Closing Date and any Option Closing Date,
there are no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued shares of Common
Stock of the Company or any security convertible or exercisable into shares of Common Stock of the Company, or any contracts or commitments
to issue or sell shares of Common Stock or any such options, warrants, rights or convertible securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.95in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10
<U>Valid Issuance of Securities, etc.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10.1
<U>Outstanding Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by
this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights
of rescission or similar rights with respect thereto or put rights, and are not subject to personal liability by reason of being such
holders; and none of such securities were issued in violation of the preemptive rights, rights of first refusal or rights of participation
of any holders of any security of the Company or similar contractual rights granted by the Company. The authorized shares of Common Stock
conform in all material respects to all statements relating thereto contained in the Registration Statement, the Disclosure Package and
the Prospectus. The offers and sales of the outstanding shares of Common Stock were at all relevant times either registered under the
Securities Act and the applicable state securities or &#8220;blue sky&#8221; laws or, based in part on the representations and warranties
of the purchasers of such Shares, exempt from such registration requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10.2
<U>Securities Sold Pursuant to this Agreement</U>. The Public Securities and Representative&#8217;s Securities have been duly authorized
for issuance and sale and, when issued and paid for pursuant to the terms of this Agreement, and the Representative&#8217;s Warrant Agreement
for the Representative&#8217;s Securities, will be validly issued, fully paid and non-assessable; the holders thereof are not and will
not be subject to personal liability by reason of being such holders; the Public Securities and Representative&#8217;s Securities are
not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted
by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Public Securities and Representative&#8217;s
Securities has been duly and validly taken. The Public Securities and Representative&#8217;s Securities conform in all material respects
to all statements with respect thereto contained in the Registration Statement, the Disclosure Package and the Prospectus. All corporate
action required to be taken for the authorization, issuance and sale of the Representative&#8217;s Warrant Agreement has been duly and
validly taken; the shares of Common Stock issuable upon exercise of the Representative&#8217;s Warrant have been duly authorized and
reserved for issuance by all necessary corporate action on the part of the Company and when paid for and issued in accordance with the
Representative&#8217;s Warrant and the Representative&#8217;s Warrant Agreement, such shares of Common Stock will be validly issued,
fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability by reason of being such holders;
and such shares of Common Stock are not and will not be subject to the preemptive rights of any holders of any security of the Company
or similar contractual rights granted by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11
<U>Registration Rights of Third Parties</U>. Other than ThinkEquity, no holders of any securities of the Company or any rights exercisable
for or convertible or exchangeable into securities of the Company have the right to require the Company to register any such securities
of the Company under the Securities Act or to include any such securities in a registration statement to be filed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12
<U>Validity and Binding Effect of Agreements</U>. This Agreement and the Representative&#8217;s Warrant Agreement have been duly and
validly authorized by the Company, and, when executed and delivered, will constitute, the valid and binding agreements of the Company,
enforceable against the Company in accordance with their respective terms, except: (i) as such enforceability may be limited by bankruptcy,
insolvency, reorganization or similar laws affecting creditors&#8217; rights generally; (ii) as enforceability of any indemnification
or contribution provision may be limited under the federal and state securities laws; and (iii) that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13
<U>No Conflicts, etc</U>. The execution, delivery and performance by the Company of this Agreement, the Representative&#8217;s Warrant
and the Representative&#8217;s Warrant Agreement and all ancillary documents, the consummation by the Company of the transactions herein
and therein contemplated and the compliance by the Company with the terms hereof and thereof, as the case may be, do not and will not,
with or without the giving of notice or the lapse of time or both: (i) result in a material breach of, or conflict with any of the terms
and provisions of, or constitute a material default under, or result in the creation, modification, termination or imposition of any
lien, charge, mortgage, pledge, security interest, claim, equity, trust or other encumbrance, preferential arrangement, defect or restriction
of any kind whatsoever (any &#8220;<B>Lien</B>&#8221;) upon any property or assets of the Company pursuant to the terms of any indenture,
mortgage, deed of trust, note, lease, loan agreement or any other agreement or instrument, franchise, license or permit to which the
Company is a party or as to which any property of the Company is a party; (ii) result in any violation of the provisions of the Company&#8217;s
Certificate of Incorporation (as the same have been amended or restated from time to time, the &#8220;<B>Charter</B>&#8221;), the by-laws
of the Company (as the same may be amended or restated from time to time) or (iii) violate any existing applicable law, rule, regulation,
ordinance, directive, judgment, writ, order or decree of any Governmental Entity as of the date hereof (including, without limitation,
those promulgated by the U.S. Environmental Protection Agency, Food and Drug Administration of the U.S. Department of Health and Human
Services (the &#8220;<B>FDA</B>&#8221;), the California Department of Pesticide Regulation or by any foreign, state or local regulatory
authority performing functions similar to those performed by the FDA), except in the cases of clauses (i) and (iii) for such breaches,
conflicts or violations which could not reasonably be expected to have a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14
<U>No Defaults; Violations</U>. No material default exists in the due performance and observance of any term, covenant or condition of
any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument
evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company is a party or by which
the Company may be bound or to which any of the properties or assets of the Company is subject. The Company is not in violation of any
term or provision of its Charter or by-laws, or in violation of any franchise, license, permit, applicable law, rule, regulation, judgment
or decree of any Governmental Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15
<U>Corporate Power; Licenses; Consents.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15.1
<U>Conduct of Business</U>. The Company has all requisite corporate power and authority, and has all necessary authorizations, approvals,
orders, licenses, certificates and permits of and from all governmental regulatory officials and bodies that it needs as of the date
hereof to conduct its business purpose as described in the Registration Statement, the Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15.2
<U>Transactions Contemplated Herein</U>. The Company has all corporate power and authority to enter into this Agreement, and the Representative&#8217;s
Warrant Agreement and to carry out the provisions and conditions hereof, and all consents, authorizations, approvals and orders required
in connection therewith have been obtained. No consent, authorization or order of, and no filing with, any court, government agency or
other body is required for the valid issuance, sale and delivery of the Public Securities and the consummation of the transactions and
agreements contemplated by this Agreement and as contemplated by the Registration Statement, the Disclosure Package and the Prospectus,
except with respect to applicable federal and state securities laws and the rules and regulations of the Exchange and the Financial Industry
Regulatory Authority, Inc. (&#8220;<B>FINRA</B>&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16
<U>D&amp;O Questionnaires</U>. To the Company&#8217;s knowledge, all information contained in the questionnaires (the &#8220;<B>Questionnaires</B>&#8221;)
completed by each of the Company&#8217;s directors, officers and principal stockholders immediately prior to the Offering (the &#8220;<B>Insiders</B>&#8221;)
as supplemented by all information concerning the Company&#8217;s directors, officers and principal stockholders as described in the
Registration Statement, the Disclosure Package and the Prospectus, as well as in the Lock-Up Agreement (as defined in Section 2.26 below),
provided to the Underwriters is true and correct in all material respects and the Company has not become aware of any information which
would cause the information disclosed in the Questionnaires to become inaccurate and incorrect in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17
<U>Litigation; Governmental Proceedings</U>. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or
governmental proceeding pending or, to the Company&#8217;s knowledge, threatened against, or involving the Company, its Subsidiary or,
to the Company&#8217;s knowledge, any executive officer or director which has not been disclosed in the Registration Statement, the Disclosure
Package and the Prospectus or in connection with the Company&#8217;s supplemental listing application for the listing of the Public Securities
on the Exchange, and which is required to be disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18
<U>Good Standing</U>. Each of the Company and its Subsidiary has been duly incorporated and validly existing as a corporation and is
in good standing under the laws of the state of its organization as of the date hereof, and is duly qualified to do business and is in
good standing in each other jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification,
except where the failure to qualify, singularly or in the aggregate, would not have or reasonably be expected to result in a Material
Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19
<U>Insurance</U>. The Company carries or is entitled to the benefits of insurance, with reputable insurers, in such amounts and covering
such risks which the Company believes are adequate, including, but not limited to, directors and officers insurance coverage at least
equal to $5,000,000 and all such insurance is in full force and effect. The Company has no reason to believe that it will not be able
(i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions
as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse
Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20
<U>Transactions Affecting Disclosure to FINRA.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.1
<U>Finder&#8217;s Fees</U>. Except as described in the Registration Statement, the Disclosure Package and the Prospectus, there are no
claims, payments, arrangements, agreements or understandings relating to the payment of a finder&#8217;s, consulting or origination fee
by the Company or any Insider with respect to the sale of the Public Securities hereunder or any other arrangements, agreements or understandings
of the Company or, to the Company&#8217;s knowledge, any of its shareholders that may affect the Underwriters&#8217; compensation, as
determined by FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.2
<U>Payments Within Twelve Months</U>. Except as described in the Registration Statement, the Disclosure Package and the Prospectus, the
Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&#8217;s fee,
consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who
raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation
or association with any FINRA member, within the twelve months prior to the date of this Agreement, other than the payment to the Underwriters
as provided hereunder in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.3
<U>Use of Proceeds</U>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its
affiliates, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.4
<U>FINRA Affiliation</U>. There is no (i) officer or director of the Company, (ii) beneficial owner of 5% or more of any class of the
Company&#8217;s securities or (iii) beneficial owner of the Company&#8217;s unregistered equity securities which were acquired during
the 180-day period immediately preceding the filing of the Registration Statement that is an affiliate or associated person of a FINRA
member participating in the Offering (as determined in accordance with the rules and regulations of FINRA). Except as disclosed in the
Registration Statement, the Disclosure Package and the Prospectus, the Company (i) does not have any material lending or other relationship
with any bank or lending affiliate of any Underwriter and (ii) does not intend to use any of the proceeds from the sale of the Public
Securities to repay any outstanding debt owed to any affiliate of any Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21
<U>Information</U>. All information provided by the Company in its FINRA questionnaire to Representative Counsel specifically for use
by Representative Counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct
and complete in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22
<U>Foreign Corrupt Practices Act</U>. None of the Company and its Subsidiary or, to the Company&#8217;s knowledge, any director, officer,
agent, employee or affiliate of the Company and its Subsidiary or any other person acting on behalf of the Company and its Subsidiary,
has, directly or indirectly, given or agreed to give any money, gift or similar benefit (other than legal price concessions to customers
in the ordinary course of business) to any customer, supplier, employee or agent of a customer or supplier, or official or employee of
any governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic
or foreign) or other person who was, is, or may be in a position to help or hinder the business of the Company (or assist it in connection
with any actual or proposed transaction) that (i) might subject the Company to any damage or penalty in any civil, criminal or governmental
litigation or proceeding, (ii) if not given in the past, might have had a Material Adverse Change or (iii) if not continued in the future,
might adversely affect the assets, business, operations or prospects of the Company. The Company has taken reasonable steps to ensure
that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the Foreign Corrupt
Practices Act of 1977, as amended, and the rules and regulations thereunder (collectively, the &#8220;<B>FCPA</B>&#8221;) or employee;
(iv) violated or is in violation of any provision of the FCPA or any applicable non-U.S. anti-bribery statute or regulation; (v) made
any bribe, rebate, payoff, influence payment, kickback or other unlawful payment; or (vi) received notice of any investigation, proceeding
or inquiry by any Governmental Entity regarding any of the matters in clauses (i)-(v) above; and the Company and, to the knowledge of
the Company, the Company&#8217;s affiliates have conducted their respective businesses in compliance with the FCPA and have instituted
and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance
therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.23
<U>Compliance with OFAC</U>. None of the Company and its Subsidiaries or, to the Company&#8217;s knowledge, any director, officer, agent,
employee or affiliate of the Company and its Subsidiary or any other person acting on behalf of the Company and its Subsidiary, is currently
subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#8220;<B>OFAC</B>&#8221;),
and the Company will not, directly or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any
person currently subject to any U.S. sanctions administered by OFAC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24
<U>Money Laundering Laws</U>. The operations of the Company and its Subsidiary are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &#8220;<B>Money Laundering Laws</B>&#8221;);
and no action, suit or proceeding by or before any Governmental Entity involving the Company with respect to the Money Laundering Laws
is pending or, to the best knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.25
<U>Forward-Looking Statements</U>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) contained in either the Registration Statement, Disclosure Package or the Prospectus has been made or reaffirmed
without a reasonable basis or has been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26
<U>Officers&#8217; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to you or to Representative
Counsel shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27
<U>Lock-Up Agreements</U>. <U>Schedule 3</U> hereto contains a complete and accurate list of each of the Company&#8217;s officers, directors
and each owner of 5% or more of the Company&#8217;s outstanding shares of Common Stock (or securities convertible into or exercisable
for shares of Common Stock) (collectively, the &#8220;<B>Lock-Up Parties</B>&#8221;). The Company has caused each of the Lock-Up Parties
to deliver to the Representative an executed Lock-Up Agreement, in the form attached hereto as <U>Exhibit B</U> (the &#8220;<B>Lock-Up
Agreement</B>&#8221;), prior to the execution of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.28
<U>Subsidiary</U>. Save Foods, Ltd., the Company&#8217;s sole Subsidiary is duly organized and in good standing under the laws of Israel,
and is in good standing in each jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification,
except where the failure to qualify would not have a Material Adverse Change. The Company&#8217;s ownership and control of each Subsidiary
is as described in the Registration Statement, the Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29
<U>Related Party Transactions.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.1
<U>Business Relationships</U>. There are no business relationships or related party transactions involving the Company or any other person
required to be described in the Registration Statement, Disclosure Package and the Prospectus that have not been described as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.2
<U>No Relationships with Customers and Suppliers</U>. No relationship, direct or indirect, exists between or among the Company on the
one hand, and the directors, officers, 5% or greater stockholders, customers or suppliers of the Company or any of the Company&#8217;s
affiliates on the other hand, which is required to be described in the Disclosure Package and the Prospectus or a document incorporated
by reference therein and which is not so described.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.3
<U>No Unconsolidated Entities</U>. There are no transactions, arrangements or other relationships between and/or among the Company, any
of its affiliates (as such term is defined in Rule 405 of the Securities Act) and any unconsolidated entity, including, but not limited
to, any structure finance, special purpose or limited purpose entity that could reasonably be expected to materially affect the Company&#8217;s
liquidity or the availability of or requirements for its capital resources required to be described in the Disclosure Package and the
Prospectus or a document incorporated by reference therein which have not been described as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.4
<U>No Loans or Advances to Affiliates</U>. There are no outstanding loans, advances (except normal advances for business expenses in
the ordinary course of business) or guarantees or indebtedness by the Company to or for the benefit of any of the officers or directors
of the Company, any other affiliates of the Company or any of their respective family members, except as disclosed in the Registration
Statement, the Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30
<U>Board of Directors</U>. The Board of Directors of the Company is comprised of the persons disclosed in the Registration Statement,
the Disclosure Package and the Prospectus. The qualifications of the persons serving as board members and the overall composition of
the board comply with the Exchange Act, the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder
(the &#8220;<B>Sarbanes-Oxley Act</B>&#8221;) applicable to the Company and the listing rules of the Exchange. At least one member of
the Audit Committee of the Board of Directors of the Company qualifies as an &#8220;audit committee financial expert,&#8221; as such
term is defined under Regulation S-K and the listing rules of the Exchange. In addition, at least a majority of the persons serving on
the Board of Directors qualify as &#8220;independent,&#8221; as defined under the listing rules of the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.95in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.31
<U>Sarbanes-Oxley Compliance.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.31.1
<U>Disclosure Controls</U>. The Company has developed and currently maintains disclosure controls and procedures that will comply with
Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material
information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company&#8217;s
Exchange Act filings and other public disclosure documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.31.2
<U>Compliance</U>. The Company is, or at the Applicable Time and on the Closing Date will be, in material compliance with the provisions
of the Sarbanes-Oxley Act applicable to it, and has implemented or will implement such programs and taken reasonable steps to ensure
the Company&#8217;s future compliance (not later than the relevant statutory and regulatory deadlines therefor) with all of the material
provisions of the Sarbanes-Oxley Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.32
<U>Accounting Controls</U>. The Company and its Subsidiary maintain systems of &#8220;internal control over financial reporting&#8221;
(as defined under Rules 13a-15 and 15d-15 under the Exchange Act Regulations) that comply with the requirements of the Exchange Act and
have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons
performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations;
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability; (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and
(iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company
is not aware of any material weaknesses in its internal controls. The Company&#8217;s auditors and the Audit Committee of the Board of
Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the design or operation of
internal controls over financial reporting which are known to the Company&#8217;s management and that have adversely affected or are
reasonably likely to adversely affect the Company&#8217; ability to record, process, summarize and report financial information; and
(ii) any fraud known to the Company&#8217;s management, whether or not material, that involves management or other employees who have
a significant role in the Company&#8217;s internal controls over financial reporting. Since the date of the latest audited financial
statements included in the Disclosure Package, there has been no change in the Company&#8217;s internal control over financial reporting
that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.33
<U>No Investment Company Status</U>. The Company is not and, after giving effect to the Offering and the application of the proceeds
thereof as described in the Registration Statement, the Disclosure Package and the Prospectus, will not be, required to register as an
&#8220;investment company,&#8221; as defined in the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.34
<U>No Labor Disputes</U>. No labor dispute with the employees of the Company or its Subsidiary exists or, to the knowledge of the Company,
is imminent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.35
<U>Intellectual Property Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its Subsidiary owns or possesses or has valid rights to use all patents, patent applications, trademarks, service marks,
trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and similar rights
(&#8220;<B>Intellectual Property Rights</B>&#8221;) necessary for the conduct of the business of the Company and its Subsidiary as currently
carried on and as described in the Registration Statement, the Disclosure Package and the Prospectus. To the knowledge of the Company,
no action or use by the Company or its Subsidiary necessary for the conduct of its business as currently carried on and as described
in the Registration Statement and the Prospectus will involve or give rise to any infringement of, or license or similar fees (other
than license or similar fees described or contemplated in the Registration Statement, the Disclosure Package and the Prospectus) for,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any Intellectual Property Rights of others. Neither the Company nor its Subsidiary has received any notice alleging any such infringement
of, license or similar fees for, or conflict with, any asserted Intellectual Property Rights of others. Except as would not reasonably
be expected to result, individually or in the aggregate, in a Material Adverse Change, (i) to the knowledge of the Company, there is
no infringement, misappropriation or violation by third parties of any of the Intellectual Property Rights owned by the Company; (ii)
there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the rights
of the Company in or to any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable
basis for any such claim, that would, individually or in the aggregate, together with any other claims in this <U>Section 2.35</U> reasonably
be expected to result in a Material Adverse Change; (iii) the Intellectual Property Rights owned by the Company and, to the knowledge
of the Company, the Intellectual Property Rights licensed to the Company have not been adjudged by a court of competent jurisdiction
invalid or unenforceable, in whole or in part, and there is no pending or, to the Company&#8217;s knowledge, threatened action, suit,
proceeding or claim by others challenging the validity or scope of any such Intellectual Property Rights, and the Company is unaware
of any facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other
claims in this <U>Section 2.35</U>, reasonably be expected to result in a Material Adverse Change; (iv) there is no pending or, to the
Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others that the Company infringes, misappropriates or otherwise
violates any Intellectual Property Rights or other proprietary rights of others, the Company has not received any written notice of such
claim and the Company is unaware of any other facts which would form a reasonable basis for any such claim that would, individually or
in the aggregate, together with any other claims in this <U>Section 2.35</U>, reasonably be expected to result in a Material Adverse
Change; and (v) to the Company&#8217;s knowledge, no employee of the Company is in or has ever been in violation in any material respect
of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation
agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates
to such employee&#8217;s employment with the Company, or actions undertaken by the employee while employed with the Company and could
reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company&#8217;s knowledge, all
material technical information developed by and belonging to the Company which has not been disclosed in a filed patent application has
been kept confidential. The Company is not a party to or bound by any options, licenses or agreements with respect to the Intellectual
Property Rights of any other person or entity that are required to be set forth in the Registration Statement, the Disclosure Package
and the Prospectus and are not described therein. The Registration Statement, the Disclosure Package and the Prospectus contain in all
material respects the same description of the matters set forth in the preceding sentence. None of the technology employed by the Company
has been obtained or is being used by the Company in violation of any contractual obligation binding on the Company or, to the Company&#8217;s
knowledge, any of its officers, directors or employees, or otherwise in violation of the rights of any persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
licenses for the use of the Intellectual Property described in the Registration Statement, the Disclosure Package and the Prospectus
are in full force and effect in all material respects and are enforceable by the Company and, to the Company&#8217;s knowledge, the other
parties thereto, in accordance with their terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting creditors&#8217; rights generally, (y) as enforceability of any indemnification or contribution provision may
be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms
of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor
may be brought. None of such agreements or instruments has been assigned by the Company, and the Company has not, and to the Company&#8217;s
knowledge, no other party is in default thereunder and no event has occurred that, with the lapse of time or the giving of notice, or
both, would constitute a default thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.36
<U>Taxes</U>. Each of the Company and its Subsidiary has filed all returns (as hereinafter defined) required to be filed with taxing
authorities prior to the date hereof or has duly obtained extensions of time for the filing thereof. Each of the Company and its Subsidiary
has paid all taxes (as hereinafter defined) shown as due on such returns that were filed and has paid all taxes imposed on or assessed
against the Company or such respective Subsidiary. The provisions for taxes payable, if any, shown on the financial statements filed
with or as part of the Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods
to and including the dates of such consolidated financial statements. Except as disclosed in writing to the Underwriters, (i) no issues
have been raised (and are currently pending) by any taxing authority in connection with any of the returns or taxes asserted as due from
the Company or its Subsidiary, and (ii) no waivers of statutes of limitation with respect to the returns or collection of taxes have
been given by or requested from the Company or its Subsidiary. The term &#8220;<B>taxes</B>&#8221; means all federal, state, local, foreign
and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service
use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or
other taxes, fees, assessments or charges of any kind whatever, together with any interest and any penalties, additions to tax or additional
amounts with respect thereto. The term &#8220;<B>returns</B>&#8221; means all returns, declarations, reports, statements and other documents
required to be filed in respect to taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.37
<U>Compliance with Environmental Laws</U>. Except as would not involve, individually or in the aggregate, a Material Change: (i) neither
the Company nor its Subsidiary is in violation of any Federal, state, local or foreign statute, law, rule, regulation, ordinance, code,
policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order,
consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation, ambient
air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations
relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances,
petroleum or petroleum products (collectively, &#8220;<B>Hazardous Materials</B>&#8221;) or to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, &#8220;<B>Environmental Laws</B>&#8221;);
(ii) the Company and its Subsidiary have all material permits, authorizations and approvals required under any applicable Environmental
Laws and are each in compliance in all material respects with their requirements; (iii) there are no pending or, to the Company&#8217;s
actual knowledge, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of
noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or its Subsidiary; and
(iv) there are no events or circumstances that might reasonably be expected to form the basis of an order for clean-up or remediation,
or an action, suit or proceeding by any private party or governmental body or agency, against or affecting the Company or any of its
subsidiaries relating to Hazardous Materials or any Environmental Laws. There has been no disposal, discharge, emission contamination
or other release of any kind at, onto or from any such property or into the environment surrounding any such property of any Hazardous
Substances with respect to which the Company has knowledge, except as could not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Change. The Company has not agreed to assume, undertake or provide indemnification for any liability of any
other person under any Environmental Law, including any obligation for cleanup or remedial action, except as could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Change. There is no pending or, to the best of the Company&#8217;s
knowledge, threatened administrative, regulatory or judicial action, claim or notice of noncompliance or violation, investigation or
proceedings relating to any Environmental Law against the Company. No property of any Company is subject to any Lien under any Environmental
Law. The Company is not subject to any order, decree, agreement or other individualized legal requirement related to any Environmental
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.38
<U>ERISA Compliance</U>. The Company, its Subsidiary and any &#8220;employee benefit plan&#8221; (as defined under the Employee Retirement
Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &#8220;<B>ERISA</B>&#8221;))
established or maintained by the Company, its Subsidiary or its &#8220;ERISA Affiliates&#8221; (as defined below) are in compliance in
all material respects with ERISA. &#8220;<B>ERISA Affiliate</B>&#8221; means, with respect to the Company, any member of any group of
organizations described in Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and
published interpretations thereunder (the &#8220;<B>Code</B>&#8221;) of which the Company or its Subsidiary is a member. No &#8220;reportable
event&#8221; (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any &#8220;employee benefit plan&#8221;
established or maintained by the Company or its Subsidiary or any of its ERISA Affiliates. No &#8220;employee benefit plan&#8221; established
or maintained by the Company or its Subsidiary or any of its ERISA Affiliates, if such &#8220;employee benefit plan&#8221; were terminated,
would have any &#8220;amount of unfunded benefit liabilities&#8221; (as defined under ERISA). None of the Company, its Subsidiary nor
any of its ERISA Affiliates has incurred or reasonably expects to incur any material liability under (i) Title IV of ERISA with respect
to termination of, or withdrawal from, any &#8220;employee benefit plan&#8221; or (ii) Sections 412, 4971, 4975 or 4980B of the Code.
Each &#8220;employee benefit plan&#8221; established or maintained by the Company, its Subsidiary or any of its ERISA Affiliates that
is intended to be qualified under Section 401(a) of the Code is so qualified and, to the knowledge of the Company, nothing has occurred,
whether by action or failure to act, which would cause the loss of such qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.39
<U>Compliance with Laws</U>. (a) Each of the Company and its Subsidiary: (i) is and at all times has been in compliance with all statutes,
rules, or regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing,
labeling, promotion, sale, offer for sale, storage, import, export storage or disposal of any product manufactured or distributed by
the Company (&#8220;<B>Applicable Laws</B>&#8221;), except as could not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Change; (ii) has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or
other correspondence or written notice from the FDA or any other governmental authority alleging or asserting noncompliance with any
Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required
by any such Applicable Laws (&#8220;<B>Authorizations</B>&#8221;); (iii) possesses all material Authorizations and such Authorizations
are valid and in full force and effect and are not in material violation of any term of any such Authorizations; (iv) has not received
written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any governmental
authority or third party alleging that any product operation or activity is in violation of any Applicable Laws or Authorizations and
has no knowledge that any such governmental authority or third party is considering any such claim, litigation, arbitration, action,
suit, investigation or proceeding; (v) has not received written notice that any governmental authority has taken, is taking or intends
to take action to limit, suspend, modify or revoke any Authorizations and has no knowledge that any such governmental authority is considering
such action; (vi) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records,
claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents,
forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct in all material respects
on the date filed (or were corrected or supplemented by a subsequent submission); and (vii) has not, either voluntarily or involuntarily,
initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety
alert, post-sale warning, &#8220;dear doctor&#8221; letter, or other notice or action relating to the alleged lack of safety or efficacy
of any product or any alleged product defect or violation and, to the Company&#8217;s knowledge, no third party has initiated, conducted
or intends to initiate any such notice or action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Regulatory Filings and Permits</U>. The Company and its Subsidiary have such permits, licenses, clearances, registrations, exemptions,
patents, franchises, certificates of need and other approvals, consents and other authorizations (&#8220;<B>Permits</B>&#8221;) issued
by the appropriate domestic or foreign regional, federal, state, or local regulatory agencies or bodies necessary to conduct the business
of the Company, or any other Permits issued by domestic or foreign regional, federal, state, or local agencies or bodies engaged in the
regulation of pharmaceuticals such as those being developed by the Company and its Subsidiary (collectively, the &#8220;<B>Regulatory
Permits</B>&#8221;), except for any of the foregoing that would not reasonably be expected to, individually or in the aggregate, have
a Material Adverse Effect; the Company is in compliance in all material respects with the requirements of the Regulatory Permits, and
all of such Regulatory Permits are valid and in full force and effect; the Company has not received any notice of proceedings relating
to the revocation, termination, modification or impairment of rights of any of the Regulatory Permits that, individually or in the aggregate,
if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to result in a Material Adverse Effect; the
Company has not failed to submit to the FDA any Permit or other filing necessary to conduct the business of the Company, any such filings
that were required to be made were in material compliance with applicable laws when filed, and no material deficiencies have been asserted
by the FDA with respect to any such filings or submissions that were made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40
<U>Title to Real and Personal Property</U>. The Company owns or leases all such properties as are necessary to the conduct of its business
as presently operated as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The Company has
good and marketable title in fee simple to all real property and good and marketable title to all personal property owned by it, in each
case free and clear of any and all Liens except such as are described in the Registration Statement, the Pricing Disclosure Package and
the Prospectus or such as do not (individually or in the aggregate) materially affect the value of such property or materially interfere
with the use made or proposed to be made of such property by the Company; and any real property and buildings held under lease or sublease
by the Company are held by them under valid, subsisting and enforceable leases with such exceptions as are not material to, and do not
materially interfere with, the use made and proposed to be made of such property and buildings by the Company. The Company has not received
any notice of any claim adverse to its ownership of any real or personal property or of any claim against the continued possession of
any real property, whether owned or held under lease or sublease by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.41
<U>Contracts Affecting Capital</U>. There are no transactions, arrangements or other relationships between and/or among the Company,
any of its affiliates (as such term is defined in Rule 405 of the Securities Act Regulations) and any unconsolidated entity, including,
but not limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially
affect the Company&#8217;s or its Subsidiary&#8217;s liquidity or the availability of or requirements for their capital resources required
to be described or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus which have not
been described or incorporated by reference as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.42
<U>Smaller Reporting Company</U>. As of the time of filing of the Registration Statement and as of the date of this Agreement, the Company
was a &#8220;smaller reporting company,&#8221; as defined in Rule 12b-2 of the Exchange Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.43
<U>Emerging Growth Company</U>. From the time of the initial confidential submission of the Registration Statement to the Commission
(or, if earlier, the first date on which the Company engaged directly in or through any Person authorized to act on its behalf in any
Testing-the Waters Communication) through the date hereof, the Company has been and is an &#8220;emerging growth company,&#8221; as defined
in Section 2(a) of the Securities Act (an &#8220;<B>Emerging Growth Company</B>&#8221;). &#8220;<B>Testing-the-Waters Communication</B>&#8221;
means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.44
<U>Industry Data</U>. The statistical, industry-related and market-related data included in each of the Registration Statement, the Disclosure
Package and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and
accurate or represent the Company&#8217;s good faith estimates that are made on the basis of data derived from such sources, and such
data agree with the sources from which they are derived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.45
<U>Ineligible Issuer</U>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the time of effectiveness
of the Registration Statement and any amendment thereto, at the earliest time thereafter that the Company or another offering participant
made a bona fide offer (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Public Securities and at the date
hereof, the Company was and is an &#8220;ineligible issuer,&#8221; as defined in Rule 405, without taking account of any determination
by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46
<U>Margin Securities</U>. The Company owns no &#8220;margin securities&#8221; as that term is defined in Regulation U of the Board of
Governors of the Federal Reserve System (the &#8220;<B>Federal Reserve Board</B>&#8221;), and none of the proceeds of the Offering will
be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring
any indebtedness which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any
of the shares of Common Stock to be considered a &#8220;purpose credit&#8221; within the meanings of Regulation T, U or X of the Federal
Reserve Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.47
<U>Exchange Act Reports</U>. The Company has filed in a timely manner all reports required to be filed pursuant to Sections 13(a), 13(e),
14 and 15(d) of the Exchange Act during the preceding 12 months (except to the extent that Section 15(d) requires reports to be filed
pursuant to Sections 13(d) and 13(g) of the Exchange Act, which shall be governed by the next clause of this sentence); and the Company
has filed in a timely manner all reports required to be filed pursuant to Sections 13(d) and 13(g) of the Exchange Act since January
1, 2020, except where the failure to timely file could not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.48
<U>Minute Books</U>. The minute books of the Company have been made available to the Underwriters and counsel for the Underwriters, and
such books (i) contain a complete summary of all meetings and actions of the board of directors (including each board committee) and
stockholders of the Company (or analogous governing bodies and interest holders, as applicable), and its Subsidiary since the time of
its respective incorporation or organization through the date of the latest meeting and action, and (ii) accurately in all material respects
reflect all transactions referred to in such minutes. There are no material transactions, agreements, dispositions or other actions of
the Company that are not properly approved and/or accurately and fairly recorded in the minute books of the Company, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.49
<U>Integration</U>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the Offering
to be integrated with prior offerings by the Company for purposes of the Securities Act that would require the registration of any such
securities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50
<U>No Stabilization</U>. Neither the Company nor, to its knowledge, any of its employees, directors or stockholders (without the consent
of the Representative) has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might
reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of
the price of any security of the Company to facilitate the sale or resale of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.51
<U>Confidentiality and Non-Competition</U>. To the Company&#8217;s knowledge, no director, officer, key employee or consultant of the
Company is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any employer
or prior employer that could materially affect his ability to be and act in his respective capacity of the Company or be expected to
result in a Material Adverse Change. Each officer, key employee or consultant of the Company has entered into a confidentiality agreement
in favor of the Company relating to the protection of the proprietary information and confidential information of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.52
<U>Corporate Records</U>. The minute books of the Company and its Subsidiary have been made available to the Underwriters and counsel
for the Underwriters, and such books (i) contain minutes of all material meetings and actions of the board of directors (including each
board committee) and stockholders of the Company, and (ii) reflect all material transactions referred to in such minutes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.53
<U>Electronic Road Show</U>. The Company has made available a Bona Fide Electronic Road Show in compliance with Rule 433(d)(8)(ii) of
the Securities Act Regulations such that no filing of any &#8220;road show&#8221; (as defined in Rule 433(h) of the Securities Act Regulations)
is required in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.54
<U>Testing-the-Waters Communications</U>. The Company has not (i) alone engaged in any Testing-the-Waters Communications, other than
Testing-the-Waters Communications with the written consent of the Representative and with entities that are qualified institutional buyers
within the meaning of Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of Rule 501
under the Securities Act and (ii) authorized anyone other than the Representative to engage in Testing-the-Waters Communications. The
Company confirms that the Representative has been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The
Company has not distributed any Written Testing-the-Waters Communications other than those listed on <U>Schedule 2-C</U> hereto. &#8220;<B>Written
Testing-the-Waters Communication</B>&#8221; means any Testing-the-Waters Communication that is a written communication within the meaning
of Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Covenants of the Company</U>. The Company covenants
and agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.2in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Amendments to Registration Statement</U>. The Company shall deliver to the Representative, prior to filing, any amendment or supplement
to the Registration Statement, Preliminary Prospectus, Disclosure Package or Prospectus proposed to be filed after the Effective Date
and not file any such amendment or supplement to which the Representative shall reasonably object in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Federal Securities Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1
<U>Compliance</U>. The Company, subject to <U>Section 3.2.2</U>, shall comply with the requirements of Rule 424(b) and Rule 430B of the
Securities Act Regulations, and will notify the Representative promptly, and confirm the notice in writing, (i) when any post-effective
amendment to the Registration Statement or any amendment or supplement to any Preliminary Prospectus, the Disclosure Package or the Prospectus
shall have been filed and when any post-effective amendment to the Registration Statement shall become effective; (ii) of the receipt
of any comments from the Commission; (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment
or supplement to any Preliminary Prospectus, the Disclosure Package or the Prospectus or for additional information; (iv) of the issuance
by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment or of
any order preventing or suspending the use of any Preliminary Prospectus, the Disclosure Package or the Prospectus, or of the suspension
of the qualification of the Public Securities and Representative&#8217;s Securities for offering or sale in any jurisdiction, or of the
initiation or threatening of any proceedings for any of such purposes or of any examination pursuant to Section 8(d) or 8(e) of the Securities
Act concerning the Registration Statement; and (v) if the Company becomes the subject of a proceeding under Section 8A of the Securities
Act in connection with the Offering of the Public Securities Representative&#8217;s Securities. The Company shall effect all filings
required under Rule 424(b) of the Securities Act Regulations, in the manner and within the time period required by Rule 424(b) (without
reliance on Rule 424(b)(8)), and shall take such steps as it deems necessary to ascertain promptly whether the form of prospectus transmitted
for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not, it will promptly file such
prospectus. The Company shall use its best efforts to prevent the issuance of any stop order, prevention or suspension and, if any such
order is issued, to obtain the lifting thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2
<U>Continued Compliance</U>. The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the
Exchange Act Regulations so as to permit the completion of the distribution of the Public Securities as contemplated in this Agreement,
the Representative&#8217;s Warrant Agreement and in the Registration Statement, the Disclosure Package and the Prospectus. If at any
time when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule 172 of the Securities Act Regulations
(&#8220;<B>Rule 172</B>&#8221;), would be) required by the Securities Act to be delivered in connection with sales of the Public Securities,
any event shall occur or condition shall exist as a result of which it is necessary, in the opinion of counsel for the Underwriters or
for the Company, to (i) amend the Registration Statement in order that the Registration Statement will not include an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading;
(ii) amend or supplement the Disclosure Package or the Prospectus in order that the Disclosure Package or the Prospectus, as the case
may be, will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein not misleading in the light of the circumstances existing at the time it is delivered to a purchaser or (iii) amend the Registration
Statement or amend or supplement the Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements
of the Securities Act or the Securities Act Regulations, the Company will promptly (A) give the Representative notice of such event;
(B) prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the Registration Statement,
the Disclosure Package or the Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed filing
or use, furnish the Representative with copies of any such amendment or supplement and (C) file with the Commission any such amendment
or supplement; <I>provided</I>, <I>however</I>, that the Company shall not file or use any such amendment or supplement to which the
Representative or counsel for the Underwriters shall reasonably object. The Company will furnish to the Underwriters such number of copies
of such amendment or supplement as the Underwriters may reasonably request. The Company has given the Representative notice of any filings
made pursuant to the Exchange Act or the Exchange Act Regulations within 48 hours prior to the Applicable Time. The Company shall give
the Representative notice of its intention to make any such filing from the Applicable Time until the later of the Closing Date and the
exercise in full or expiration of the Over-allotment Option specified in Section 1.2 hereof and will furnish the Representative with
copies of the related document(s) a reasonable amount of time prior to such proposed filing, as the case may be, and will not file or
use any such document to which the Representative or counsel for the Underwriters shall reasonably object.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3
<U>Exchange Act Registration</U>. For a period of three (3) years after the date of this Agreement, the Company shall use its best efforts
to maintain the registration of the shares of Common Stock under the Exchange Act. The Company shall not deregister the shares of Common
Stock under the Exchange Act without the prior written consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.4
<U>Free Writing Prospectuses</U>. The Company agrees that, unless it obtains the prior written consent of the Representative, it shall
not make any offer relating to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
constitute a &#8220;free writing prospectus,&#8221; or a portion thereof, required to be filed by the Company with the Commission or
retained by the Company under Rule 433; <I>provided</I>, <I>however</I>, that the Representative shall be deemed to have consented to
each Issuer General Use Free Writing Prospectus hereto and any &#8220;road show that is a written communication&#8221; within the meaning
of Rule 433(d)(8)(i) that has been reviewed by the Representative. The Company represents that it has treated or agrees that it will
treat each such free writing prospectus consented to, or deemed consented to, by the Underwriters as an &#8220;issuer free writing prospectus,&#8221;
as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including
timely filing with the Commission where required, legending and record keeping. If at any time following issuance of an Issuer Free Writing
Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would
conflict with the information contained in the Registration Statement or included or would include an untrue statement of a material
fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
existing at that subsequent time, not misleading, the Company will promptly notify the Underwriters and will promptly amend or supplement,
at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.5
<U>Testing-the-Waters Communications</U>. If at any time following the distribution of any Written Testing-the-Waters Communication there
occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include
an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances existing at that subsequent time, not misleading, the Company shall promptly notify the Representative
and shall promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such
untrue statement or omission. The Company will promptly notify the Representative of (i) any distribution by the Company of Written Testing-the-Waters
Communications and (ii) any request by the Commission for information concerning the Written Testing-the-Waters Communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<U>Delivery to the Underwriters of Registration Statements</U>. The Company has delivered or made available or shall deliver or make
available to the Representative and counsel for the Representative, without charge, signed copies of the Registration Statement as originally
filed and each amendment thereto (including exhibits filed therewith or incorporated by reference therein and documents incorporated
or deemed to be incorporated by reference therein) and signed copies of all consents and certificates of experts, and will also deliver
to the Underwriters, without charge, a conformed copy of the Registration Statement as originally filed and each amendment thereto (without
exhibits) for each of the Underwriters. The copies of the Registration Statement and each amendment thereto furnished to the Underwriters
will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent
permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<U>Delivery to the Underwriters of Prospectuses</U>. The Company has delivered or made available or will deliver or make available to
each Underwriter, without charge, as many copies of each Preliminary Prospectus as such Underwriter reasonably requested, and the Company
hereby consents to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to each Underwriter,
without charge, during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule
172, would be) required to be delivered under the Securities Act, such number of copies of the Prospectus (as amended or supplemented)
as such Underwriter may reasonably request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will
be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted
by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<U>Events Requiring Notice to the Representative</U>. The Company shall use its best efforts to cause the Registration Statement to remain
effective with a current prospectus for at least nine (9) months after the Applicable Time, and shall notify the Representative immediately
and confirm the notice in writing: (i) of the issuance by the Commission of any stop order or of the initiation, or the threatening,
of any proceeding for that purpose; (ii) of the issuance by any state securities commission of any proceedings for the suspension of
the qualification of the Public Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any
proceeding for that purpose; (iii) of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration
Statement or Prospectus; (iv) of the receipt of any comments or request for any additional information from the Commission; and (v) of
the happening of any event during the period described in this <U>Section 3.5</U> that, in the judgment of the Company, makes any statement
of a material fact made in the Registration Statement, the Disclosure Package or the Prospectus untrue or that requires the making of
any changes in (a) the Registration Statement in order to make the statements therein not misleading, or (b) in the Disclosure Package
or the Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
If the Commission or any state securities commission shall enter a stop order or suspend such qualification at any time, the Company
shall make every reasonable effort to obtain promptly the lifting of such order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<U>Review of Financial Statements.</U> For a period of five (5) years after the date of this Agreement, the Company, at its expense,
shall cause its regularly engaged independent registered public accounting firm to review (but not audit) the Company&#8217;s financial
statements for each of the three fiscal quarters immediately preceding the announcement of any quarterly financial information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<U>Listing</U>. The Company shall use its best efforts to maintain the listing of the shares of Common Stock (including the Public Securities)
on the Exchange for at least three (3) years from the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
<U>Financial Public Relations Firm</U>. The Company has retained a financial public relations firm reasonably acceptable to the Representative
and the Company, which is RedChip Companies Inc., which firm shall be experienced in assisting issuers in public offerings of securities
and in their relations with their security holders, and shall retain such firm or another firm reasonably acceptable to the Representative
for a period of not less than two (2) years after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
<U>Reports to the Representative</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.1
<U>Periodic Reports, etc</U>. For a period of three (3) years after the date of this Agreement, the Company shall furnish or make available
to the Representative copies of such financial statements and other periodic and special reports as the Company from time to time furnishes
generally to holders of any class of its securities and also promptly furnish to the Representative: (i) a copy of each periodic report
the Company shall be required to file with the Commission under the Exchange Act and the Exchange Act Regulations; (ii) a copy of every
press release and every news item and article with respect to the Company or its affairs which was released by the Company; (iii) a copy
of each Form 8-K prepared and filed by the Company; (iv) five copies of each registration statement filed by the Company under the Securities
Act; (v) a copy of each report or other communication furnished to stockholders and (vi) such additional documents and information with
respect to the Company and the affairs of any future subsidiaries of the Company as the Representative may from time to time reasonably
request; <I>provided</I>, <I>however</I>, the Representative shall sign, if requested by the Company, a Regulation FD compliant confidentiality
agreement which is reasonably acceptable to the Representative and Representative Counsel in connection with the Representative&#8217;s
receipt of such information. Documents filed with the Commission pursuant to its EDGAR system shall be deemed to have been delivered
to the Representative pursuant to this <U>Section 3.9.1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.2
<U>Transfer Agent; Transfer Sheets</U>. For a period of three (3) years after the date of this Agreement, the Company shall retain a
transfer agent and registrar acceptable to the Representative (the &#8220;<B>Transfer Agent</B>&#8221;) and shall furnish to the Representative
at the Company&#8217;s sole cost and expense such transfer sheets of the Company&#8217;s securities as the Representative may reasonably
request, including the daily and monthly consolidated transfer sheets of the Transfer Agent and DTC. Action Stock Corp. is acceptable
to the Representative to act as Transfer Agent for the shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.3
<U>Trading Reports</U>. During such time as the Public Securities are listed on the Exchange, the Company shall provide to the Representative,
at the Company&#8217;s expense, such reports published by Exchange relating to price trading of the Public Securities, as the Representative
shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10
<U>Payment of Expenses</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10.1
The Company hereby agrees to pay on each of the Closing Date and the Option Closing Date, if any, to the extent not paid at the Closing
Date, all expenses incident to the performance of the obligations of the Company under this Agreement, including, but not limited to:
(i) all filing fees and communication expenses relating to the registration of Public Securities to be issued and sold in the Offering
with the Commission; (ii) all filing fees associated with the review of the Offering by FINRA; (iii) all fees and expenses relating to
the listing of such Common Stock on the Exchange, including any fees charged by The Depository Trust Company (DTC) for new securities;
(iv) all fees, expenses and disbursements relating to background checks of the Company&#8217;s officers and directors in an amount not
to exceed $15,000 in the aggregate; (v) all fees, expenses and disbursements relating to the registration, qualification or exemption
of the Public Securities under the securities laws of such foreign jurisdictions as the Representative may reasonably designate; (vi)
the costs of all mailing and printing of the underwriting documents (including, without limitation, this Agreement, any blue sky surveys
and, if appropriate, any agreement among underwriters, selected dealers&#8217; agreement, underwriters&#8217; questionnaire and power
of attorney), Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary and
final Prospectuses as the Representative may reasonably deem necessary; (vii) the costs and expenses of the public relations firm referred
to in Section 3.8 hereof; (viii) the costs of preparing, printing and delivering certificates representing the Public Securities; (ix)
fees and expenses of the Transfer Agent for the shares of Common Stock; (x) stock transfer and/or stamp taxes, if any, payable upon the
transfer of securities from the Company to the Underwriters; (xi) to the extent approved by the Company in writing, the costs associated
with post-Closing advertising of the Offering in the national editions of The Wall Street Journal and The New York Times; (xii) up to
$3,000 of the costs associated with bound volumes of the public offering materials as well as commemorative mementos and lucite tombstones,
each of which the Company or its designee will provide within a reasonable time after the Closing in such quantities as the Representative
may reasonably request; (xiii) the fees and expenses of the Company&#8217;s accountants; (xiv) the fees and expenses of the Company&#8217;s
legal counsel and other agents and representatives; (xv) the reasonable and documented fees and expenses of Underwriter&#8217;s legal
counsel not to exceed $75,000; (xvi) the $29,500 cost associated with the Underwriters&#8217; use of Ipreo&#8217;s book building, prospectus
tracking and compliance software for the Offering; (xvii) $10,000 for data services and communications expenses; (xviii) up to $10,000
of ThinkEquity&#8217;s actual accountable &#8220;road show&#8221; expenses; and (xix) up to $30,000 of ThinkEquity&#8217;s market making
and trading, and clearing firm settlement expenses for the Offering. Notwithstanding the foregoing, the total reimbursable amount pursuant
to clauses (xii), (xv), (xvi), (xvii), (xviii) and (xix) shall not exceed $100,000 in the aggregate. The Representative may deduct from
the net proceeds of the Offering payable to the Company on the Closing Date, or the Option Closing Date, if any, the expenses set forth
herein to be paid by the Company to the Underwriters, provided, however, that in the event that the Offering is terminated, the Company
agrees to reimburse the Underwriters pursuant to Section 8.3 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10.2
<U>Non-accountable Expenses</U>. The Company further agrees that, in addition to the expenses payable pursuant to Section 3.10.1, on
the Closing Date it shall pay to the Representative, by deduction from the net proceeds of the Offering contemplated herein, a non-accountable
expense allowance equal to one percent (1.0%) of the gross proceeds received by the Company from the sale of the Public Securities),
less the Advance (as such term is defined in Section 8.3 hereof), provided, however, that in the event that the Offering is terminated,
the Company agrees to reimburse the Underwriters pursuant to Section 8.3 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11
<U>Application of Net Proceeds</U>. The Company shall apply the net proceeds from the Offering received by it in a manner consistent
with the application thereof described under the caption &#8220;Use of Proceeds&#8221; in the Registration Statement, the Disclosure
Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12
<U>Delivery of Earnings Statements to Security Holders</U>. The Company shall make generally available to its security holders as soon
as practicable, but not later than the first day of the fifteenth (15<SUP>th</SUP>) full calendar month following the date of this Agreement,
an earnings statement (which need not be certified by independent registered public accounting firm unless required by the Securities
Act or the Securities Act Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities Act)
covering a period of at least twelve (12) consecutive months beginning after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13
<U>Stabilization</U>. Neither the Company nor, to its knowledge, any of its employees, directors or shareholders (without the consent
of the Representative) has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might
reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of
the price of any security of the Company to facilitate the sale or resale of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14
<U>Internal Controls</U>. The Company shall maintain a system of internal accounting controls sufficient to provide reasonable assurances
that: (i) transactions are executed in accordance with management&#8217;s general or specific authorization; (ii) transactions are recorded
as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability for assets;
(iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv) the recorded
accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any
differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15
<U>Accountants</U>. As of the date of this Agreement, the Company shall continue to retain a nationally recognized independent registered
public accounting firm for a period of at least three (3) years after the date of this Agreement. The Representative acknowledges that
KPMG International is acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16
<U>FINRA</U>. The Company shall advise the Representative (who shall make an appropriate filing with FINRA) if it is or becomes aware
that (i) any officer or director of the Company, (ii) any beneficial owner of 5% or more of any class of the Company&#8217;s securities
or (iii) any beneficial owner of the Company&#8217;s unregistered equity securities which were acquired during the 180 days immediately
preceding the filing of the Registration Statement is or becomes an affiliate or associated person of a FINRA member participating in
the Offering (as determined in accordance with the rules and regulations of FINRA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17
<U>No Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&#8217; responsibility to the Company is solely
contractual in nature and that none of the Underwriters or their affiliates or any selling agent shall be deemed to be acting in a fiduciary
capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other
transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18
<U>Restriction on Continuous Offerings</U>. Notwithstanding the restrictions contained in Section 3.18, the Company, on behalf of itself
and any successor entity, agrees that, without the prior written consent of the Representative, it will not, for a period of 24 months
after the date of this Agreement, directly or indirectly in any &#8220;at-the-market&#8221; or continuous equity transaction, offer to
sell, sell, contract to sell, grant any option to sell or otherwise dispose of shares of capital stock of the Company or any securities
convertible into or exercisable or exchangeable for shares of capital stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19
<U>Company Lock-Up Agreements</U>. The Company, on behalf of itself and any successor entity, agrees that, without the prior written
consent of the Representative, it will not for a period of three (3) months after the date of this Agreement (the &#8220;<B>Lock-Up Period</B>&#8221;),
(i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock
of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file
or cause to be filed any registration statement with the Commission relating to the offering of any shares of capital stock of the Company
or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; or (iii) complete any offering
of debt securities of the Company, other than entering into a line of credit with a traditional bank or (iv) enter into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company,
whether any such transaction described in clause (i), (ii), (iii) or (iv) above is to be settled by delivery of shares of capital stock
of the Company or such other securities, in cash or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
restrictions contained in this <U>Section 3.19 </U>shall not apply to (i) the shares of Common Stock to be sold hereunder, (ii) the issuance
by the Company of shares of Common Stock upon the exercise of a stock option or warrant or the conversion of a security outstanding on
the date hereof, which is disclosed in the Registration Statement, Disclosure Package and Prospectus, provided that such options, warrants,
and securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise
price, exchange price or conversion price of such securities or to extend the term of such securities, (iii) the issuance by the Company
of stock options, shares of capital stock of the Company or other awards under any equity compensation plan of the Company, provided
that in each of (ii) and (iii) above, the underlying shares shall be restricted from sale during the entire Lock-Up Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20
<U>Release of D&amp;O Lock-up Period</U>. If the Representative, in its sole discretion, agrees to release or waive the restrictions
set forth in the Lock-Up Agreements described in Section 2.26 hereof for an officer or director of the Company and provide the Company
with notice of the impending release or waiver at least three (3) Business Days before the effective date of the release or waiver, the
Company agrees to announce the impending release or waiver by a press release substantially in the form of <U>Exhibit B</U> hereto through
a major news service at least two (2) Business Days before the effective date of the release or waiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21
<U>Blue Sky Qualifications</U>. The Company shall use its best efforts, in cooperation with the Underwriters, if necessary, to qualify
the Public Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic or
foreign) as the Representative may designate and to maintain such qualifications in effect so long as required to complete the distribution
of the Public Securities; <I>provided</I>, <I>however</I>, that the Company shall not be obligated to file any general consent to service
of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or
to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22
<U>Reporting Requirements</U>. The Company, during the period when a prospectus relating to the Public Securities is (or, but for the
exception afforded by Rule 172, would be) required to be delivered under the Securities Act, will file all documents required to be filed
with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange Act Regulations. Additionally,
the Company shall report the use of proceeds from the issuance of the Public Securities as may be required under Rule 463 under the Securities
Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.23
<U>Press Releases</U>. Prior to the Closing Date and any Option Closing Date, the Company shall not issue any press release or other
communication directly or indirectly or hold any press conference with respect to the Company, its condition, financial or otherwise,
or earnings, business affairs or business prospects (except for routine oral marketing communications in the ordinary course of business
and consistent with the past practices of the Company and of which the Representative is notified), without the prior written consent
of the Representative, which consent shall not be unreasonably withheld, unless in the judgment of the Company and its counsel, and after
notification to the Representative, such press release or communication is required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24
<U>Sarbanes-Oxley</U>. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company shall
at all times comply with all applicable provisions of the Sarbanes-Oxley Act in effect from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.25
<U>Emerging Growth Company Status</U>. The Company shall promptly notify the Representative if the Company ceases to be an Emerging Growth
Company at any time prior to the later of (i) completion of the distribution of the Public Securities within the meaning of the Securities
Act and (ii) fifteen (15) days following the completion of the Lock-Up Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Conditions of Underwriters&#8217; Obligations</U>. The obligations of the Underwriters to purchase and pay for the Public Securities,
as provided herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of the date
hereof and as of each of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of officers of the
Company made pursuant to the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the following
conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Regulatory Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.1
<U>Commission Actions; Required Filings</U>. At each of the Closing Date and any Option Closing Date, no stop order suspending the effectiveness
of the Registration Statement or any post-effective amendment thereto shall have been issued under the Securities Act, no order preventing
or suspending the use of any Preliminary Prospectus or the Prospectus shall have been issued and no proceedings for any of those purposes
shall have been instituted or are pending or, to the Company&#8217;s knowledge, contemplated by the Commission. The Company has complied
with each request (if any) from the Commission for additional information. A prospectus containing the Rule 430B Information shall have
been filed with the Commission in the manner and within the time frame required by Rule 424(b) under the Securities Act Regulations (without
reliance on Rule 424(b)(8)) or a post-effective amendment providing such information shall have been filed with, and declared effective
by, the Commission in accordance with the requirements of Rule 430B under the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.2
<U>FINRA Clearance</U>. On or before the date of this Agreement, the Representative shall have received clearance from FINRA as to the
amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.3
<U>Exchange Stock Market Clearance</U>. On the Closing Date, the Company&#8217;s Common Stock (including the Firm Shares and the shares
of Common Stock underlying the Option Shares) shall have been approved for listing on the Exchange. On the first Option Closing Date
(if any), the Company&#8217;s Common Stock (including the shares of Common Stock underlying the Option Shares) shall have been approved
for listing on the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Company Counsel Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.1
<U>Closing Date Opinion of Counsel to the Company</U>. On the Closing Date, the Representative shall have received the favorable opinions
of McDermott Will &amp; Emery LLP, special corporate and securities counsel to the Company, and a written statement providing certain
&#8220;10b-5&#8221; negative assurances, dated the Closing Date and addressed to the Representative, substantially in a form reasonably
acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.2
<U>Closing Date Opinion of Counsel to the Company</U>. On the Closing Date, the Representative shall have received the favorable opinions
of Meitar Law Offices, special Israeli counsel to the Company, and a written statement providing certain &#8220;10b-5&#8221; negative
assurances, dated the Closing Date and addressed to the Representative, substantially in a form reasonably acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.3
<U>Closing Date Opinion of Regulatory Counsel to the Company</U>. On the Closing Date, the Representative shall have received the favorable
opinion of Covington &amp; Burling LLP, regulatory counsel to the Company, and a written statement providing certain &#8220;10b-5&#8221;
negative assurances, dated the Closing Date and addressed to the Representative, substantially in a form acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.4
<U>Closing Date Opinion of Intellectual Property Counsel to the Company</U>. On the Closing Date, the Representative shall have received
the favorable opinion of Geyra Kesten Frydman IP Law, intellectual property counsel to the Company, and a written statement providing
certain &#8220;10b-5&#8221; negative assurances, dated the Closing Date and addressed to the Representative, substantially in a form
acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.5
<U>Option Closing Date Opinions of Counsel</U>. On the Option Closing Date, if any, the Representative shall have received the favorable
opinions of each counsel listed in Sections 4.2.1, 4.2.2, 4.2.3 and 4.2.4, dated the Option Closing Date, addressed to the Representative
and in form and substance reasonably satisfactory to the Representative, confirming as of the Option Closing Date, the statements made
by such counsels in their respective opinions delivered on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.5
<U>Reliance</U>. In rendering such opinions, such counsel may rely: (i) as to matters involving the application of laws other than the
laws of the United States and jurisdictions in which they are admitted, to the extent such counsel deems proper and to the extent specified
in such opinion, if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to the Representative) of other
counsel reasonably acceptable to the Representative, familiar with the applicable laws; and (ii) as to matters of fact, to the extent
they deem proper, on certificates or other written statements of officers of the Company and officers of departments of various jurisdictions
having custody of documents respecting the corporate existence or good standing of the Company, provided that copies of any such statements
or certificates shall be delivered to Representative Counsel if requested. The opinions described in Sections 4.2.1, 4.2.2, 4.2.3 and
4.2.4 and any opinion relied upon by such counsel shall include a statement to the effect that it may be relied upon by Representative
Counsel in its opinion delivered to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Comfort Letters.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.1
<U>Cold Comfort Letter</U>. At the time this Agreement is executed you shall have received a cold comfort letters from KPMG International
and Halperin Ilanit, Certified Public Accountants (Israel) containing statements and information of the type customarily included in
accountants&#8217; comfort letters with respect to the financial statements and certain financial information contained or incorporated
or deemed incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, addressed to the Representative
and in form and substance satisfactory in all respects to you and to the KPMG International and Halperin Ilanit, Certified Public Accountants
(Israel), respectively, dated as of the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.2
<U>Bring-down Comfort Letter</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received
from KPMG International a letter, dated as of the Closing Date or the Option Closing Date, as applicable, to the effect that KPMG International
reaffirms the statements made in its letter furnished pursuant to Section 4.3.1, except that the specified date referred to shall be
a date not more than three (3) business days prior to the Closing Date or the Option Closing Date, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Officers&#8217; Certificates.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.1
<U>Officers&#8217; Certificate</U>. The Company shall have furnished to the Representative a certificate, dated the Closing Date and
any Option Closing Date (if such date is other than the Closing Date), of its Chief Executive Officer and its Chief Financial Officer
stating that (i) such officers have carefully examined the Registration Statement, the Disclosure Package, any Issuer Free Writing Prospectus
and the Prospectus and, in their opinion, the Registration Statement and each amendment thereto, as of the Applicable Time and as of
the Closing Date (or any Option Closing Date if such date is other than the Closing Date) did not include any untrue statement of a material
fact and did not omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading,
and the Disclosure Package, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is other than
the Closing Date), any Issuer Free Writing Prospectus as of its date and as of the Closing Date (or any Option Closing Date if such date
is other than the Closing Date), and the Prospectus and each amendment or supplement thereto, as of the respective date thereof and as
of the Closing Date, did not include any untrue statement of a material fact and did not omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances in which they were made, not misleading, (ii) since the effective date
of the Registration Statement, no event has occurred which should have been set forth in a supplement or amendment to the Registration
Statement, the Disclosure Package or the Prospectus, (iii) to the best of their knowledge after reasonable investigation, as of the Closing
Date (or any Option Closing Date if such date is other than the Closing Date), the representations and warranties of the Company in this
Agreement are true and correct and the Company has complied with all agreements and satisfied all conditions on its part to be performed
or satisfied hereunder at or prior to the Closing Date (or any Option Closing Date if such date is other than the Closing Date), and
(iv) there has not been, subsequent to the date of the most recent audited financial statements included or incorporated by reference
in the Disclosure Package, any material adverse change in the financial position or results of operations of the Company, or any change
or development that, singularly or in the aggregate, would involve a material adverse change or a prospective material adverse change,
in or affecting the condition (financial or otherwise), results of operations, business, assets or prospects of the Company, except as
set forth in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.2
<U>Secretary&#8217;s Certificate</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have
received a certificate of the Company signed by the Secretary of the Company, dated the Closing Date or the Option Date, as the case
may be, respectively, certifying: (i) that each of the Charter and Bylaws is true and complete, has not been modified and is in full
force and effect; (ii) that the resolutions of the Company&#8217;s Board of Directors relating to the Offering are in full force and
effect and have not been modified; (iii) as to the accuracy and completeness of all correspondence between the Company or its counsel
and the Commission; and (iv) as to the incumbency of the officers of the Company. The documents referred to in such certificate shall
be attached to such certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.3.
<U>Chief Financial Officer&#8217;s Certificate</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative
shall have received a certificate of the Chief Financial Officer of the Company, dated the Closing Date or the Option Date, as the case
may be, respectively, with respect to the accuracy of certain information contained in the Registration Statement, the Disclosure Package
and the Prospectus, in a form reasonably acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>No Material Changes</U>. Prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been
no material adverse change or development involving a prospective material adverse change in the condition or prospects or the business
activities, financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the Registration
Statement and no change in the capital stock or debt of the Company, the Disclosure Package and the Prospectus; (ii) no action, suit
or proceeding, at law or in equity, shall have been pending or threatened against the Company or any Insider before or by any court or
federal or state commission, board or other administrative agency wherein an unfavorable decision, ruling or finding may materially adversely
affect the business, operations, prospects or financial condition or income of the Company, except as set forth in the Registration Statement,
the Disclosure Package and the Prospectus; (iii) no stop order shall have been issued under the Securities Act and no proceedings therefor
shall have been initiated or threatened by the Commission; (iv) no action shall have been taken and no law, statute, rule, regulation
or order shall have been enacted, adopted or issued by any Governmental Entity which would prevent the issuance or sale of the Public
Securities or materially and adversely affect or potentially materially and adversely affect the business or operations of the Company;
(v) no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction shall have
been issued which would prevent the issuance or sale of the Public Securities or materially and adversely affect or potentially materially
and adversely affect the business or operations of the Company and (vi) the Registration Statement, the Disclosure Package and the Prospectus
and any amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance
with the Securities Act and the Securities Act Regulations and shall conform in all material respects to the requirements of the Securities
Act and the Securities Act Regulations, and neither the Registration Statement, the Disclosure Package, the Prospectus nor any amendment
or supplement thereto shall contain any untrue statement of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>No Material Misstatement or Omission</U>. The Underwriters shall not have discovered and disclosed to the Company on or prior to the
Closing Date and any Option Closing Date that the Registration Statement or any amendment or supplement thereto contains an untrue statement
of a fact which, in the opinion of counsel for the Underwriters, is material or omits to state any fact which, in the opinion of such
counsel, is material and is required to be stated therein or is necessary to make the statements therein not misleading, or that the
Registration Statement, Disclosure Package, any Issuer Free Writing Prospectus or the Prospectus or any amendment or supplement thereto
contains an untrue statement of fact which, in the opinion of such counsel, is material or omits to state any fact which, in the opinion
of such counsel, is material and is necessary in order to make the statements, in the light of the circumstances under which they were
made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Corporate Proceedings</U>. All corporate proceedings and other legal matters incident to the authorization, form and validity of each
of this Agreement, the Representative&#8217;s Warrant Agreement, the Public Securities, the Registration Statement, the Disclosure Package,
each Issuer Free Writing Prospectus, if any, and the Prospectus and all other legal matters relating to this Agreement, the Representative&#8217;s
Warrant Agreement and the transactions contemplated hereby and thereby shall be reasonably satisfactory in all material respects to counsel
for the Underwriters, and the Company shall have furnished to such counsel all documents and information that they may reasonably request
to enable them to pass upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Delivery of Agreements.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.1
<U>Deliveries on the Date of this Agreement</U>. On or before the date of this Agreement, the Company shall have delivered to the Representative
executed copies of the Lock-Up Agreements from each of the persons listed in <U>Schedule 3</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.2
<U>Closing Date Deliveries</U>. On the Closing Date, the Company shall have delivered to the Representative an executed copy of the Representative&#8217;s
Warrant Agreements in the names as the Representative shall request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Additional Documents</U>. At the Closing Date and at each Option Closing Date (if any), Representative Counsel shall have been furnished
with such documents and opinions as they may require for the purpose of enabling Representative Counsel to deliver an opinion to the
Underwriters, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions,
herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Public Securities and the
Representative Securities as herein contemplated shall be satisfactory in form and substance to the Representative and Representative
Counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 31.5pt; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Indemnification.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.95in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Indemnification of the Underwriters.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1
<U>General</U>. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless each Underwriter, its affiliates
and each of its and their respective directors, officers, members, employees, representatives, partners, shareholders, affiliates, counsel
and agents and each person, if any, who controls any such Underwriter within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act (collectively the &#8220;<B>Underwriter Indemnified Parties</B>,&#8221; and each an &#8220;<B>Underwriter Indemnified
Party</B>&#8221;), against any and all loss, liability, claim, damage and expense whatsoever (including but not limited to any and all
legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened,
or any claim whatsoever, whether arising out of any action between any of the Underwriter Indemnified Parties and the Company or between
any of the Underwriter Indemnified Parties and any third party, or otherwise) to which they or any of them may become subject under the
Securities Act, the Exchange Act or any other statute or at common law or otherwise or under the laws of foreign countries (a &#8220;Claim&#8221;),
arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in (i) the Registration Statement,
the Disclosure Package, the Preliminary Prospectus, the Prospectus or any Issuer Free Writing Prospectus or in any Written Testing-the-Waters
Communication (as from time to time each may be amended and supplemented); (ii) any materials or information provided to investors by,
or with the approval of, the Company in connection with the marketing of the Offering, including any &#8220;road show&#8221; or investor
presentations made to investors by the Company (whether in person or electronically); (iii) any application or other document or written
communication (in this <U>Section 5</U>, collectively called &#8220;<B>application</B>&#8221;) executed by the Company or based upon
written information furnished by the Company in any jurisdiction in order to qualify the Public Securities under the securities laws
thereof or filed with the Commission, any state securities commission or agency, the Exchange or any other national securities exchange;
or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading, unless such statement or omission was made in reliance
upon, and in conformity with, the Underwriters&#8217; Information, or (iv) otherwise arising in connection with or allegedly in connection
with the Offering. The Company also agrees that it will reimburse each Underwriter Indemnified Party for all fees and expenses (including
but not limited to any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation,
commenced or threatened, or any claim whatsoever, whether arising out of any action between any of the Underwriter Indemnified Parties
and the Company or between any of the Underwriter Indemnified Parties and any third party, or otherwise) (collectively, the &#8220;<B>Expenses</B>&#8221;),
and further agrees wherever and whenever possible to advance payment of Expenses as they are incurred by an Underwriter Indemnified Party
in investigating, preparing, pursuing or defending any Claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2
<U>Procedure</U>. If any action is brought against an Underwriter Indemnified Party in respect of which indemnity may be sought against
the Company pursuant to Section 5.1.1, such Underwriter Indemnified Party shall promptly notify the Company in writing of the institution
of such action and the Company shall assume the defense of such action, including the employment and fees of counsel (subject to the
approval of such Underwriter Indemnified Party) and payment of actual expenses if an Underwriter Indemnified Party requests that the
Company do so. Such Underwriter Indemnified Party shall have the right to employ its or their own counsel in any such case, but the fees
and expenses of such counsel shall be at the expense of the Company, and shall be advanced by the Company. The Company shall not be liable
for any settlement of any action effected without its consent (which shall not be unreasonably withheld). In addition, the Company shall
not, without the prior written consent of the Underwriters, settle, compromise or consent to the entry of any judgment in or otherwise
seek to terminate any pending or threatened action in respect of which advancement, reimbursement, indemnification or contribution may
be sought hereunder (whether or not such Underwriter Indemnified Party is a party thereto) unless such settlement, compromise, consent
or termination (i) includes an unconditional release of each Underwriter Indemnified Party, acceptable to such Underwriter Indemnified
Party, from all liabilities, expenses and claims arising out of such action for which indemnification or contribution may be sought and
(ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any Underwriter
Indemnified Party.</FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.05in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Indemnification of the Company</U>. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company,
its directors, its officers who signed the Registration Statement and persons who control the Company within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the
foregoing indemnity from the Company to the several Underwriters, as incurred, but only with respect to untrue statements or omissions
made in the Registration Statement, any Preliminary Prospectus, the Disclosure Package or Prospectus or any amendment or supplement thereto
or in any application, in reliance upon, and in strict conformity with, the Underwriters&#8217; Information. In case any action shall
be brought against the Company or any other person so indemnified based on any Preliminary Prospectus, the Registration Statement, the
Disclosure Package or Prospectus or any amendment or supplement thereto or any application, and in respect of which indemnity may be
sought against any Underwriter, such Underwriter shall have the rights and duties given to the Company, and the Company and each other
person so indemnified shall have the rights and duties given to the several Underwriters by the provisions of Section 5.1.2. The Company
agrees promptly to notify the Representative of the commencement of any litigation or proceedings against the Company or any of its officers,
directors or any person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act, in connection with the issuance and sale of the Public Securities or in connection with the Registration Statement, the
Disclosure Package, the Prospectus or any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.95in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.95in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.15in; text-align: justify; text-indent: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1
<U>Contribution Rights</U>. If the indemnification provided for in this <U>Section 5</U> shall for any reason be unavailable to or insufficient
to hold harmless an indemnified party under <U>Section 5.1 or 5.2</U> in respect of any loss, claim, damage or liability, or any action
in respect thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute
to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof,
(i) in such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters,
on the other, from the Offering of the Public Securities, or (ii) if the allocation provided by clause (i) above is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also
the relative fault of the Company, on the one hand, and the Underwriters, on the other, with respect to the statements or omissions that
resulted in such loss, claim, damage or liability, or action in respect thereof, as well as any other relevant equitable considerations.
The relative benefits received by the Company, on the one hand, and the Underwriters, on the other, with respect to such Offering shall
be deemed to be in the same proportion as the total net proceeds from the Offering of the Public Securities purchased under this Agreement
(before deducting expenses) received by the Company, as set forth in the table on the cover page of the Prospectus, on the one hand,
and the total underwriting discounts and commissions received by the Underwriters with respect to the securities purchased under this
Agreement, as set forth in the table on the cover page of the Prospectus, on the other hand. The relative fault shall be determined by
reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact
relates to information supplied by the Company or the Underwriters, the intent of the parties and their relative knowledge, access to
information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would not
be just and equitable if contributions pursuant to this <U>Section 5.3.1</U> were to be determined by pro rata allocation (even if the
Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take into account the equitable
considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability,
or action in respect thereof, referred to above in this <U>Section 5.3.1</U> shall be deemed to include, for purposes of this <U>Section
5.3.1</U>, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any
such action or claim. Notwithstanding the provisions of this <U>Section 5.3.1</U> in no event shall an Underwriter be required to contribute
any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect
to the Offering of the Public Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by
reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation.</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2
<U>Contribution Procedure</U>. Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of notice
of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made
against another party (&#8220;contributing party&#8221;), notify the contributing party of the commencement thereof, but the failure
to so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution
hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or
its representative of the commencement thereof within the aforesaid 15 days, the contributing party will be entitled to participate therein
with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable to any
party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution
on account of any settlement of any claim, action or proceeding affected by such party seeking contribution without the written consent
of such contributing party. The contribution provisions contained in this <U>Section 5.3.2</U> are intended to supersede, to the extent
permitted by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available. Each Underwriter&#8217;s
obligations to contribute pursuant to this <U>Section 5.3</U> are several and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Default by an Underwriter.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Default Not Exceeding 10% of Firm Shares or Option Shares</U>. If any Underwriter or Underwriters shall default in its or their obligations
to purchase the Firm Shares or the Option Shares, if the Over-allotment Option is exercised hereunder, and if the number of the Firm
Shares or Option Shares with respect to which such default relates does not exceed in the aggregate 10% of the number of Firm Shares
or Option Shares that all Underwriters have agreed to purchase hereunder, then such Firm Shares or Option Shares to which the default
relates shall be purchased by the non-defaulting Underwriters in proportion to their respective commitments hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Default Exceeding 10% of Firm Shares or Option Shares</U>. In the event that the default addressed in Section 6.1 relates to more
than 10% of the Firm Shares or Option Shares, the Representative may in its discretion arrange for it or for another party or parties
to purchase such Firm Shares or Option Shares to which such default relates on the terms contained herein. If, within one (1) Business
Day after such default relating to more than 10% of the Firm Shares or Option Shares, the Representative does not arrange for the purchase
of such Firm Shares or Option Shares, then the Company shall be entitled to a further period of one (1) Business Day within which to
procure another party or parties satisfactory to the Representative to purchase said Firm Shares or Option Shares on such terms. In the
event that neither the Representative nor the Company arrange for the purchase of the Firm Shares or Option Shares to which a default
relates as provided in this <U>Section 6</U>, this Agreement will automatically be terminated by the Representative or the Company without
liability on the part of the Company (except as provided in Sections 3.10 and 5 hereof) or the several Underwriters (except as provided
in Section 5 hereof); provided, however, that if such default occurs with respect to the Option Shares, this Agreement will not terminate
as to the Firm Shares; and provided, further, that nothing herein shall relieve a defaulting Underwriter of its liability, if any, to
the other Underwriters and to the Company for damages occasioned by its default hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>Postponement of Closing Date</U>. In the event that the Firm Shares or Option Shares to which the default relates are to be purchased
by the non-defaulting Underwriters, or are to be purchased by another party or parties as aforesaid, the Representative or the Company
shall have the right to postpone the Closing Date or Option Closing Date for a reasonable period, but not in any event exceeding five
(5) Business Days, in order to effect whatever changes may thereby be made necessary in the Registration Statement, the Disclosure Package
or the Prospectus or in any other documents and arrangements, and the Company agrees to file promptly any amendment to the Registration
Statement, the Disclosure Package or the Prospectus that in the opinion of counsel for the Underwriter may thereby be made necessary.
The term &#8220;<B>Underwriter</B>&#8221; as used in this Agreement shall include any party substituted under this <U>Section 6</U> with
like effect as if it had originally been a party to this Agreement with respect to such shares of Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Additional Covenants.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Board Composition and Board Designations</U>. The Company shall ensure that: (i) the qualifications of the persons serving as members
of the Board of Directors and the overall composition of the Board comply with the Sarbanes-Oxley Act, the Exchange Act and the listing
rules of the Exchange or any other national securities exchange, as the case may be, in the event the Company seeks to have any of its
securities listed on another exchange or quoted on an automated quotation system, and (ii) if applicable, at least one member of the
Audit Committee of the Board of Directors qualifies as an &#8220;audit committee financial expert,&#8221; as such term is defined under
Regulation S-K and the listing rules of the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Prohibition on Press Releases and Public Announcements</U>. The Company shall not issue press releases or engage in any other publicity,
without the Representative&#8217;s prior written consent, for a period ending at 5:00 p.m., Eastern time, on the first (1<SUP>st</SUP>)
Business Day following the forty (40<SUP>th</SUP>) day after the Closing Date, other than normal and customary releases issued in the
ordinary course of the Company&#8217;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
<U>Right of First Refusal</U>. Pursuant to that certain underwriting agreement by and between the Company and ThinkEquity LLC (formerly
known as ThinkEquity, a division of Fordham Financial Management, Inc.) dated May 13, 2021 (the &#8220;<B>May 2021 Underwriting Agreement</B>&#8221;),
pursuant to Section 7.3 (Right of First Refusal) thereof, the Company granted ThinkEquity, among other things, an irrevocable right of
first refusal for thirty-six (36 months) (or until May 18, 2024), to act as sole investment banker, sole book-runner, and/or sole placement
agent, in ThinkEquity&#8217;s sole discretion, for each and every future public and private equity and debt offering, including all equity
linked financings, during such thirty six (36) month period, on terms customary to the representative. Notwithstanding any contrary provision
contained in this Agreement, any election hereunder or any termination of this Agreement, and whether or not this Agreement is otherwise
carried out, the terms and conditions of the May 2021 Underwriting Agreement, including, but not limited to, Section 7.3 (Right of First
Refusal) shall remain in full force and effect and enforceable against the Company and shall not be in any way affected by, such election
or termination or failure to carry out the terms of this Agreement or any part hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Effectiveness of this Agreement and Termination Thereof.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
<U>Effectiveness of the Agreement</U>. This Agreement shall become effective when both the Company and the Representative have executed
the same and delivered counterparts of such signatures to the other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
<U>Termination</U>. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i) if
any domestic or international event or act or occurrence has materially disrupted, or in your opinion will in the immediate future materially
disrupt, general securities markets in the United States; or (ii) if trading on the New York Stock Exchange or the Nasdaq Stock Market
LLC shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges
for prices for securities shall have been required by FINRA or by order of the Commission or any other government authority having jurisdiction;
or (iii) if the United States shall have become involved in a new war or an increase in major hostilities; or (iv) if a banking moratorium
has been declared by a New York State or federal authority; or (v) if a moratorium on foreign exchange trading has been declared which
materially adversely impacts the United States securities markets; or (vi) if the Company shall have sustained a material loss by fire,
flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have
been insured, will, in your opinion, make it inadvisable to proceed with the delivery of the Firm Shares or Option Shares; or (vii) if
the Company is in material breach of any of its representations, warranties or covenants hereunder; or (viii) if the Representative shall
have become aware after the date hereof of such a material adverse change in the conditions or prospects of the Company, or such adverse
material change in general market conditions as in the Representative&#8217;s judgment would make it impracticable to proceed with the
offering, sale and/or delivery of the Public Securities or to enforce contracts made by the Underwriters for the sale of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
<U>Expenses</U>. Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters, pursuant
to Section 6.2 above, in the event that this Agreement shall not be carried out for any reason whatsoever, within the time specified
herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Underwriters their actual
and accountable out-of-pocket expenses related to the transactions contemplated herein then due and payable (including the fees and disbursements
of Representative Counsel) up to $100,000, inclusive of the $20,000 advance for accountable expenses previously paid by the Company to
the Representative (the &#8220;<B>Advance</B>&#8221;) and upon demand the Company shall pay the full amount thereof to the Representative
on behalf of the Underwriters; provided, however, that such expense cap in no way limits or impairs the indemnification and contribution
provisions of this Agreement. Notwithstanding the foregoing, any advance received by the Representative will be reimbursed to the Company
to the extent not actually incurred in compliance with FINRA Rule 5110(g)(4)(A).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
<U>Survival of Indemnification</U>. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any
termination of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Section 5 shall remain in
full force and effect and shall not be in any way affected by, such election or termination or failure to carry out the terms of this
Agreement or any part hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
<U>Representations, Warranties, Agreements to Survive</U>. All representations, warranties and agreements contained in this Agreement
or in certificates of officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless
of (i) any investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter,
its officers or directors or any person controlling the Company or (ii) delivery of and payment for the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Miscellaneous.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
<U>Notices</U>. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed
(registered or certified mail, return receipt requested), personally delivered or sent by e-mail or facsimile transmission and confirmed
and shall be deemed given when so delivered, e-mailed or faxed and confirmed or if mailed, two (2) days after such mailing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Representative:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 41<SUP>st</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Head of Investment Banking</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
(212) 349-2550</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e-mail:
<U>notices@think-equity.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blank
Rome LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1271
Avenue of the Americas</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Leslie Marlow, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
No. (917) 332-3824</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e-mail:
leslie.marlow@blankrome.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; color: blue"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Habarzel
7</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
Aviv, Israel 6971011</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
David Palach, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
No.: +97237175788</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e-mail:
david@savefoods.co</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice), in each case, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">McDermott
Will &amp; Emery LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
Vanderbilt Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10017-3852</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
David Huberman, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax
No.: (312) 277-9028</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e-mail:
dhuberman@mwe.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
<U>Headings</U>. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3
<U>Absence of Fiduciary Relationship.</U> The Company acknowledges and agrees that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
each Underwriter&#8217;s responsibility to the Company is solely contractual in nature, each Underwriter has been retained solely to
act as an underwriter in connection with the Offering and no fiduciary, advisory or agency relationship between the Company and the Underwriters
has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether either the Representative
has advised or is advising the Company on other matters;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the price of the Public Securities set forth in this Agreement was established by the Company following discussions and arm&#8217;s-length
negotiations with the Representative, and the Company are capable of evaluating and understanding, and understands and accepts, the terms,
risks and conditions of the transactions contemplated by this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
it has been advised that the Representative and their respective affiliates are engaged in a broad range of transactions which may involve
interests that differ from those of the Company and that the Underwriters have no obligation to disclose such interests and transactions
to the Company by virtue of any fiduciary, advisory or agency relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4
<U>Research Analyst Independence</U>. The Company acknowledges that each Underwriter&#8217;s research analysts and research departments
are required to be independent from its investment banking division and are subject to certain regulations and internal policies, and
that such Underwriter&#8217;s research analysts may hold views and make statements or investment recommendations and/or publish research
reports with respect to the Company and/or the Offering that differ from the views of their investment banking division. The Company
acknowledges that each Underwriter is a full service securities firm and as such from time to time, subject to applicable securities
laws, rules and regulations, may effect transactions for its own account or the account of its customers and hold long or short positions
in debt or equity securities of the Company; provided, however, that nothing in this <U>Section 9.4</U> shall relieve the Underwriter
of any responsibility or liability it may otherwise bear in connection with activities in violation of applicable securities laws, rules
or regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5
<U>Amendment</U>. This Agreement may only be amended by a written instrument executed by each of the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6
<U>Entire Agreement</U>. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection
with this Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof. Notwithstanding
anything to the contrary set forth herein, it is understood and agreed by the parties hereto that all other terms and conditions of (i)
that certain engagement letter between the Company and ThinkEquity LLC dated July 15, 2022 shall remain in full force and effect and
(ii) the May 2021 Underwriting Agreement, including, but not limited to Section 7.3 (Right of First Refusal) thereof, shall remain in
full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7
<U>Binding Effect</U>. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters,
the Company, and the controlling persons, directors and officers referred to in Section 5.2 hereof, and their respective successors,
legal representatives, heirs and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy
or claim under or in respect of or by virtue of this Agreement or any provisions herein contained. The term &#8220;successors and assigns&#8221;
shall not include a purchaser, in its capacity as such, of securities from any of the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.8
<U>Governing Law; Consent to Jurisdiction; Trial by Jury</U>. This Agreement shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that
any action, proceeding or claim against it arising out of, or relating in any way to this Agreement shall be brought and enforced in
the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company may be served by transmitting
a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in
Section 9.1 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. The Company agrees that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies)
all of its reasonable attorneys&#8217; fees and expenses relating to such action or proceeding and/or incurred in connection with the
preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates)
and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.9
<U>Execution in Counterparts</U>. This Agreement may be executed in one or more counterparts, and by the different parties hereto in
separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the
same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered
to each of the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall
constitute valid and sufficient delivery thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.10
<U>Waiver, etc</U>. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not
be deemed or construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision
hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach,
non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument
executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance
or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[<I>Signature
Page Follows</I>]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided
below for that purpose, whereupon this letter shall constitute a binding agreement between us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours, </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SAVE
    FOODS, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
David Palach</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Palach </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmed
as of the date first written above</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mentioned,
on behalf of itself and as</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representative
of the several Underwriters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">named
on <U>Schedule 1</U> hereto:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ThinkEquity
    LLC </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Eric Lord</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
Lord</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head
of Investment Banking</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Save
Foods, Inc. &ndash; Underwriting Agreement Signature Page]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>SCHEDULE
1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Underwriter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Number of</B></FONT></P>
                                                                                 <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Firm Shares</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to be</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchased</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option Shares</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to be Purchased if</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>the Over-</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Allotment Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>is Fully Exercised</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%; text-align: left">ThinkEquity LLC</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 21%; text-align: center">1,600,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 21%; text-align: center">240,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; font-weight: bold">TOTAL</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center">1,600,000</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center">240,000</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
2-A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Firm Shares: 1,600,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Option Shares: 240,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Firm Share: $3.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Discount per Share: $0.21</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Non-accountable expense allowance per Share: $0.03</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
to Company per Share (before expenses): $2.79</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-2A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
2-B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer
General Use Free Writing Prospectuses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-2B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
2-C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Written
Testing-the-Waters Communications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-2C</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
3</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>List
of Lock-Up Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Directors
and Officers of the Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
David Palach, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Dan Sztybel, Chief Executive Officer of Save Foods Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Lital Barda, Chief Financial Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
Neta Matis, Chief Operating Officer and Head of Science of Save Foods Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
Amitay Weiss, Chairman of the Board of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
Israel Berenshtein, Director</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
Eliahou Arbib, Director</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
Udi Kalifi, Director</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
Ronen Rosenbloom, Director</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Greater
Than 5% Stockholders of the Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 38.25pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Amir Uziel / Amir Uziel Economic Consultant Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 38.25pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
L.I.A Pure Capital Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 38.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Representative&#8217;s Warrant Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&bull;],
2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 41<SUP>st</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Representative of the several Underwriters named on <U>Schedule 1</U> to the Underwriting Agreement referenced below</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that ThinkEquity LLC (the &#8220;<B>Representative</B>&#8221;), proposes to enter into an Underwriting Agreement
(the &#8220;<B>Underwriting Agreement</B>&#8221;) with Save Foods, Inc., a Delaware corporation (the &#8220;<B>Company</B>&#8221;), providing
for the public offering (the &#8220;<B>Public Offering</B>&#8221;) of shares of common stock, par value $0.0001 per share, of the Company
(the &#8220;<B>Shares</B>&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
induce the Representative to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that, without
the prior written consent of the Representative, the undersigned will not, during the period commencing on the date hereof and ending
[three (3) months]<SUP>1</SUP>[six (6) months]<SUP>2</SUP> after the date of the final prospectus (the &#8220;<B>Prospectus</B>&#8221;)
relating to the Public Offering (the &#8220;<B>Lock-Up Period</B>&#8221;), (1) offer, pledge, sell, contract to sell, grant, lend, or
otherwise transfer or dispose of, directly or indirectly, any Shares or any securities convertible into or exercisable or exchangeable
for Shares, whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires
the power of disposition (collectively, the &#8220;<B>Lock-Up Securities</B>&#8221;); (2) enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such
transaction described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise; (3) make any
demand for or exercise any right with respect to the registration of any Lock-Up Securities; or (4) publicly disclose the intention to
make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating to any Lock-Up
Securities. Notwithstanding the foregoing, and subject to the conditions below, the undersigned may transfer Lock-Up Securities without
the prior written consent of the Representative in connection with (a) transactions relating to Lock-Up Securities acquired in open market
transactions after the completion of the Public Offering; <U>provided</U> that no filing under Section 16(a) of the Securities Exchange
Act of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;), or other public announcement shall be required or shall be voluntarily
made in connection with subsequent sales of Lock-Up Securities acquired in such open market transactions; (b) transfers of Lock-Up Securities
as a <I>bona fide</I> gift, by will or intestacy or to a family member or trust for the benefit of a family member (for purposes of this
lock-up agreement, &#8220;family member&#8221; means any relationship by blood, marriage or adoption, not more remote than first cousin);
(c) transfers of Lock-Up Securities to a charity or educational institution; or (d) if the undersigned, directly or indirectly, controls
a corporation, partnership, limited liability company or other business entity, any transfers of Lock-Up Securities to any shareholder,
partner or member of, or owner of similar equity interests in, the undersigned, as the case may be; <U>provided</U> that in the case
of any transfer pursuant to the foregoing clauses (b), (c) or (d), (i) any such transfer shall not involve a disposition for value, (ii)
each transferee shall sign and deliver to the Representative a lock-up agreement substantially in the form of this lock-up agreement
and (iii) no filing under Section 16(a) of the Exchange Act shall be required or shall be voluntarily made. The undersigned also agrees
and consents to the entry of stop transfer instructions with the Company&#8217;s transfer agent and registrar against the transfer of
the undersigned&#8217;s Lock-Up Securities except in compliance with this lock-up agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP>Six
(6) months in the case of officers and directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP>Three (3) months in the case of any other 5% or greater holder of shares of common stock</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees that, prior to engaging in any transaction or taking any other action that is subject to the terms of this lock-up
agreement during the period from the date hereof to and including the 34<SUP>th</SUP> day following the expiration of the initial Lock-Up
Period, the undersigned will give notice thereof to the Company and will not consummate any such transaction or take any such action
unless it has received written confirmation from the Company that the Lock-Up Period has expired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the undersigned is an officer or director of the Company, (i) the undersigned agrees that the foregoing restrictions shall be equally
applicable to any issuer-directed or &#8220;friends and family&#8221; Shares that the undersigned may purchase in the Public Offering;
(ii) the Representative agrees that, at least three (3) business days before the effective date of any release or waiver of the foregoing
restrictions in connection with a transfer of Lock-Up Securities, the Representative will notify the Company of the impending release
or waiver; and (iii) the Company has agreed in the Underwriting Agreement to announce the impending release or waiver by press release
through a major news service at least two (2) business days before the effective date of the release or waiver. Any release or waiver
granted by the Representative hereunder to any such officer or director shall only be effective two (2) business days after the publication
date of such press release. The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit
a transfer of Lock-Up Securities not for consideration and (b) the transferee has agreed in writing to be bound by the same terms described
in this lock-up agreement to the extent and for the duration that such terms remain in effect at the time of such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
provision in this agreement shall be deemed to restrict or prohibit the exercise, exchange or conversion by the undersigned of any securities
exercisable or exchangeable for or convertible into Shares, as applicable; <U>provided</U> that the undersigned does not transfer the
Shares acquired on such exercise, exchange or conversion during the Lock-Up Period, unless otherwise permitted pursuant to the terms
of this lock-up agreement. In addition, no provision herein shall be deemed to restrict or prohibit the entry into or modification of
a so-called &#8220;10b5-1&#8221; plan at any time (other than the entry into or modification of such a plan in such a manner as to cause
the sale of any Lock-Up Securities within the Lock-Up Period).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that the Company and the Representative are relying upon this lock-up agreement in proceeding toward consummation
of the Public Offering. The undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon the
undersigned&#8217;s heirs, legal representatives, successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
lock-up agreement shall automatically terminate and be void and of no further force or effect if: (i) the Underwriters notify the Company
that they do not intend to proceed with the Public Offering prior to the execution of the Underwriting Agreement; and (ii) the Company
notifies the representative that it does not intend to proceed with the Public Offering prior to the execution of the Underwriting Agreement;
and (iii) the Underwriting Agreement is not executed by October 31, 2022, or if the Underwriting Agreement (other than the provisions
thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Shares to be sold thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
or not the Public Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will only
be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
page follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    - Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Signatory, in the case of entities - Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title
    of Signatory, in the case of entities - Please Print)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Press Release</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75in 0pt 0pt; text-align: right; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Date]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 56.03pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods, Inc., a company incorporated under the laws of Delaware (the &#8220;<B>Company</B>&#8221;), announced today that ThinkEquity LLC,
acting as representative for the underwriters in the Company&#8217;s recent public offering of the Company&#8217;s shares of common stock
and warrants, is [waiving] [releasing] a lock-up restriction with respect to _________ the Company&#8217;s shares of common stock held
by [certain officers, directors or other security holders] [an officer, director or security holder] of the Company. The [waiver] [release]
will take effect on _________, 20___, and the shares may be sold on or after such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 56.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 56.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or sale is
prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration
under the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>








<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Representative&#8217;s Warrant Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE
THIS PURCHASE WARRANT OR BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE
ECONOMIC DISPOSITION OF THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE COMMENCEMENT
DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) THINKEQUITY LLC, OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING,
OR (II) A BONA FIDE OFFICER OR PARTNER OF THINKEQUITY LLC, OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS 180 DAYS FROM THE COMMENCEMENT DATE OF THE OFFERING]. VOID
AFTER 5:00 P.M., EASTERN TIME,[___________________] [DATE THAT IS FIVE YEARS FROM THE COMMENCEMENT DATE OF THE OFFERING].</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
TO PURCHASE COMMON STOCK </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAVE
FOODS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [______]<SUP>1</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: [_____], 2023</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT TO PURCHASE COMMON STOCK (the &#8220;<U>Warrant</U>&#8221;) certifies that, for value received, _____________ or its assigns
(the &#8220;<U>Holder</U>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after [______], 2023, which is one hundred eighty (180) days following the Commencement Date (the &#8220;<U>Initial
Exercise Date</U>&#8221;) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to at 5:00 p.m. (New York time) on, [_____], 2027,
the date that is five (5) years following the Commencement Date (the &#8220;<U>Termination Date</U>&#8221;) but not thereafter, to subscribe
for and purchase from Save Foods, Inc., a Delaware corporation (the &#8220;<U>Company</U>&#8221;), up to [_____]<SUP>1</SUP> shares of
Common Stock, par value $0.0001 per share (the &#8220;<U>Common Stock</U>&#8221;), of the Company (the &#8220;<U>Warrant Shares</U>&#8221;),
as subject to adjustment hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Affiliate</U>&#8221;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Business
Day</U>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided that banks shall not be deemed to be authorized or obligated to be closed due to a &#8220;shelter
in place,&#8221; &#8220;non-essential employee&#8221; or similar closure of physical branch locations at the direction of any governmental
authority if such banks&#8217; electronic funds transfer systems (including for wire transfers) are open for use by customers on such
day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP>Total warrant shares equal to 5% of the aggregate number of Common Stock issued and sold in the Offering).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#8220;<U>Commencement
Date</U>&#8221; means [____], 2022, the date on which sales of the securities issued in the Offering commenced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Commission</U>&#8221;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Exchange
Act</U>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Offering</U>&#8221;
shall have the meaning ascribed to such term in <U>Section 1.2.1</U> of the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Person</U>&#8221;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Rule
144</U>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Securities
Act</U>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Trading
Day</U>&#8221; means a day on which the New York Stock Exchange is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Trading
Market</U>&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>Underwriting
Agreement</U>&#8221; means that certain Underwriting Agreement, dated as of [___], 2022, by and between, the Company and ThinkEquity
LLC, as representatives of the underwriters set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<U>VWAP</U>&#8221;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of a share of Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX as applicable, (c) if Common Stock
is not then listed or quoted for trading on the OTCQB or OTCQX and if prices for Common Stock are then reported in the &#8220;Pink Sheets&#8221;
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of the Common Stock as determined
by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which
shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial
Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may
designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly
executed facsimile copy (or e-mail attachment) of the Notice of Exercise Form annexed hereto. Within two (2) Trading Days following the
date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice
of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within five (5) Trading Days of the date the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within two (2) Business Days of receipt
of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of the Common Stock under this Warrant shall be <B>$[__]</B>, subject to adjustment
hereunder (the &#8220;<U>Exercise Price</U>&#8221;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. In lieu of exercising this Warrant by delivering the aggregate Exercise Price by wire transfer or cashier&#8217;s
check, at any time on or after the Initial Exercise Date, at the election of the Holder this Warrant may also be exercised, in whole
or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive the number of
Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined
    in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading
    Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular
    trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
    of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
    Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
    pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a &#8220;cashless exercise,&#8221; the parties acknowledge and agree that in accordance with Section
3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the
holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to
take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
    <U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
    by its transfer agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The
    Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<U>DWAC</U>&#8221;) if the Company is then
    a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
    to or resale of the Warrant Shares by Holder, or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
    limitations pursuant to Rule 144 and, in either case, the Warrant Shares have been sold by the Holder prior to the Warrant Share
    Delivery Date (as defined below), and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register
    in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise
    to the address specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days after the delivery to the
    Company of the Notice of Exercise (such date, the &#8220;<U>Warrant Share Delivery Date</U>&#8221;), provided that the Company shall
    not be obligated to deliver the Warrant Shares hereunder unless the Company has received the aggregate Exercise Price on or before
    the Warrant Shares Delivery Date. If the Warrant Shares can be delivered via DWAC, the transfer agent shall have received from the
    Company, at the expense of the Company, any legal opinions or other documentation required by it to deliver such Warrant Shares without
    legend (subject to receipt by the Company of reasonable back up documentation from the Holder, including with respect to affiliate
    status) and, if applicable and requested by the Company prior to the Warrant Share Delivery Date, the transfer agent shall have received
    from the Holder a confirmation of sale of the Warrant Shares (provided the requirement of the Holder to provide a confirmation as
    to the sale of Warrant Shares shall not be applicable to the issuance of unlegended Warrant Shares upon a cashless exercise of this
    Warrant if the Warrant Shares are then eligible for resale pursuant to Rule 144(b)(1)). The Warrant Shares shall be deemed to have
    been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of
    such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or
    by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior to
    the issuance of such shares, having been paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
    to a Notice of Exercise by the second Trading Day following the Warrant Share Delivery Date, the Company shall pay to the Holder,
    in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP
    of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on
    the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after the second Trading Day following
    such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
    <U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
    of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder
    a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new
    Warrant shall in all other respects be identical with this Warrant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
    <U>Rescission Rights</U>. If the Company fails to cause its transfer agent to deliver to the Holder the Warrant Shares pursuant to
    Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; <U>provided</U>,
    <U>however</U>, that the Holder shall be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise
    notice concurrently with the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the
    restoration of Holder&#8217;s right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement
    warrant certificate evidencing such restored right).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
    <U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available
    to the Holder, if the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to an exercise
    on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open
    market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
    of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;<U>Buy-In</U>&#8221;),
    then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including
    brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the
    number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2)
    the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either
    reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case
    such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued
    had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
    Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock
    with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence
    the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts
    payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein
    shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
    limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver
    shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
    <U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
    of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
    shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
    by the Exercise Price or round up to the next whole share.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
    <U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
    tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid
    by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by
    the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name
    of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed
    by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
    tax incidental thereto. The Company shall pay all transfer agent fees required for same-day processing of any Notice of Exercise
    and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required
    for same-day electronic delivery of the Warrant Shares.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
    <U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
    of this Warrant, pursuant to the terms hereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">viii.
    <U>Signature</U>. This Section 2 and the exercise form attached hereto set forth the totality of the procedures required of the Holder
    in order to exercise this Purchase Warrant. Without limiting the preceding sentences, no ink-original exercise form shall be required,
    nor shall any medallion guarantee (or other type of guarantee or notarization) of any exercise form be required in order to exercise
    this Purchase Warrant. No additional legal opinion, other information or instructions shall be required of the Holder to exercise
    this Purchase Warrant. The Company shall honor exercises of this Purchase Warrant and shall deliver Shares underlying this Purchase
    Warrant in accordance with the terms, conditions and time periods set forth herein.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
    <U>Holder&#8217;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have
    the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to
    such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates,
    and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates), would beneficially own
    in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
    of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon
    exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common
    Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the
    Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities
    of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise
    analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates. Except as set forth in the
    preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d)
    of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is
    not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely
    responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section
    2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
    with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
    of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation
    to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each
    case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of
    such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
    Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining
    the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected
    in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent
    public announcement by the Company or (C) a more recent written notice by the Company or the Company&#8217;s transfer agent setting
    forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two
    Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the
    number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
    of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares
    of Common Stock was reported. The &#8220;<U>Beneficial Ownership Limitation</U>&#8221; shall be 9.99% of the number of shares of
    the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of
    this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of
    this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common
    Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by
    the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will
    not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
    be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this
    paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
    contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
    in this paragraph shall apply to a successor holder of this Warrant. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price
of this Warrant will not be adjusted in the event that the Company or any Subsidiary thereof, as applicable, sells or grants any option
to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option
to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise
Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &#8220;<U>Purchase Rights</U>&#8221;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the
Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other
than cash dividends) or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way
of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<U>Distribution</U>&#8221;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, to the extent that the Holder&#8217;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock,
(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each
a &#8220;<U>Fundamental Transaction</U>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &#8220;<U>Alternate Consideration</U>&#8221;) receivable by holders of Common Stock as a result of such Fundamental
Transaction for each share of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &#8220;<U>Successor Entity</U>&#8221;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and
power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor
Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the
number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be mailed a notice to the Holder at its last address as it shall appear
upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified,
stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock
of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to provide such notice or any defect
therein shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice
provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of its Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Pursuant to FINRA Rule 5110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant
shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call
transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately
following the Commencement Date, except the transfer of any security:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    operation of law or by reason of reorganization of the Company;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    any FINRA member firm participating in the offering and the officers or partners thereof, if all securities so transferred remain
    subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the aggregate amount of securities of the Company held by the Holder or related person do not exceed 1% of the securities being offered;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
    is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages
    or otherwise directs investments by the fund, and participating members in the aggregate do not own more than 10% of the equity in
    the fund; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a)
    for the remainder of the time period.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the foregoing restriction, any applicable securities laws and the conditions set forth in Section 4(d), this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant
full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&#8220;<U>Warrant Register</U>&#8221;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5. Registration Rights.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.1
Demand Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1
<U>Grant of Right</U>. The Company, upon written demand (a &#8220;<U>Demand Notice</U>&#8221;) of the Holder(s) of at least 51% of the
Warrants and/or the underlying Warrant Shares (&#8220;<U>Majority Holders</U>&#8221;), agrees to register, on one occasion, all or any
portion of the Warrant Shares underlying the Warrants (collectively, the &#8220;<U>Registrable Securities</U>&#8221;). On such occasion,
the Company will file a registration statement with the Commission covering the Registrable Securities within thirty (30) days after
receipt of a Demand Notice and use its commercially reasonable efforts to have the registration statement declared effective promptly
thereafter, subject to compliance with review by the Commission; provided, however, that the Company shall not be required to comply
with a Demand Notice if the Company has filed a registration statement with respect to which the Holder is entitled to piggyback registration
rights pursuant to Section 5.2 hereof and either: (i) the Holder has elected to participate in the offering covered by such registration
statement or (ii) if such registration statement relates to an underwritten primary offering of securities of the Company, until the
offering covered by such registration statement has been withdrawn or until thirty (30) days after such offering is consummated. The
sole demand for registration may be made at any time beginning on the Initial Exercise Date and expiring on the fifth anniversary of
the Commencement Date in accordance with FINRA Rule 5110(g)(8)(C). The Company covenants and agrees to give written notice of its receipt
of any Demand Notice by any Holder(s) to all other registered Holders of the Warrants and/or the Registrable Securities within ten (10)
days after the date of the receipt of any such Demand Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2
Terms. The Company shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to Section 5.1.1,
but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent
them in connection with the sale of the Registrable Securities. The Company agrees to use its commercially reasonable efforts to cause
the filing required herein to become effective promptly and to qualify or register the Registrable Securities in such States as are reasonably
requested by the Holder(s); provided, however, that in no event shall the Company be required to register the Registrable Securities
in a State in which such registration would cause: (i) the Company to be obligated to register or license to do business in such State
or submit to general service of process in such State, or (ii) the principal stockholders of the Company to be obligated to escrow their
shares of capital stock of the Company. The Company shall cause any registration statement filed pursuant to the demand right granted
under Section 5.1.1 to remain effective for a period of at least twelve (12) consecutive months after the date that the Holders of the
Registrable Securities covered by such registration statement are first given the opportunity to sell all of such securities. The Holders
shall only use the prospectuses provided by the Company to sell the Warrant Shares covered by such registration statement, and will immediately
cease to use any prospectus furnished by the Company if the Company advises the Holder that such prospectus may no longer be used due
to a material misstatement or omission. Notwithstanding the provisions of this Section 5.1.2, the Holder shall be entitled to a demand
registration under this Section 5.1.2 on only one (1) occasion and such demand registration right shall terminate on the fifth anniversary
of the Commencement Date in accordance with FINRA Rules 5110(g)(8)(B) and 5110(g)(8)(C).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.2
&#8220;Piggy-Back&#8221; Registration.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.1
<U>Grant of Right</U>. In addition to the demand right of registration described in Section 5.1 hereof, the Holder shall have the right,
for a period of no more than five (5) years from the Initial Exercise Date in accordance with FINRA Rule 5110(g)(8)(D), to include the
Registrable Securities as part of any other registration of securities filed by the Company (other than in connection with a transaction
contemplated by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any equivalent form); provided, however,
that if, solely in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s)
thereof shall, in its reasonable discretion, impose a limitation on the number of Registrable Securities that may be included in the
Registration Statement because, in such underwriter(s)&#8217; judgment, marketing or other factors dictate such limitation is necessary
to facilitate public distribution, then the Company shall be obligated to include in such Registration Statement only such limited portion
of the Registrable Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit.
Any exclusion of Registrable Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion
to the number of Registrable Securities sought to be included by such Holders; provided, however, that the Company shall not exclude
any Registrable Securities unless the Company has first excluded all outstanding securities, the holders of which are not entitled to
inclusion of such securities in such Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.2
<U>Terms</U>. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 5.2.1
hereof, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders
to represent them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company
shall furnish the then Holders of outstanding Registrable Securities with not less than thirty (30) days written notice prior to the
proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration statement
filed by the Company during the two (2) period following the Initial Exercise Date until such time as all of the Registrable Securities
have been sold by the Holder. The holders of the Registrable Securities shall exercise the &#8220;piggy-back&#8221; rights provided for
herein by giving written notice within ten (10) days of the receipt of the Company&#8217;s notice of its intention to file a registration
statement. Except as otherwise provided in this Warrant, there shall be no limit on the number of times the Holder may request registration
under this Section 5.2.2; provided, however, that such registration rights shall terminate on the third (3<SUP>rd</SUP>) anniversary
of the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.3
General Terms</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1
<U>Indemnification</U>. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration
statement hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section
20 (a) of the Exchange Act against all loss, claim, damage, expense or liability (including all reasonable attorneys&#8217; fees and
other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which any of them may become
subject under the Securities Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent
and with the same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriters contained in Section
5.1 of the Underwriting Agreement. The Holder(s) of the Registrable Securities to be sold pursuant to such registration statement, and
their successors and assigns, shall severally, and not jointly, indemnify the Company, against all loss, claim, damage, expense or liability
(including all reasonable attorneys&#8217; fees and other expenses reasonably incurred in investigating, preparing or defending against
any claim whatsoever) to which they may become subject under the Securities Act, the Exchange Act or otherwise, arising from information
furnished by or on behalf of such Holders, or their successors or assigns, in writing, for specific inclusion in such registration statement
to the same extent and with the same effect as the provisions contained in Section 5.2 of the Underwriting Agreement pursuant to which
the Underwriters have agreed to indemnify the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.3.2
Exercise of Warrants</U>. Nothing contained in this Warrant shall be construed as requiring the Holder(s) to exercise their Warrants
prior to or after the initial filing of any registration statement or the effectiveness thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.3
<U>Documents Delivered to Holders</U>. The Company shall furnish to each Holder participating in any of the foregoing offerings and to
each underwriter of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of counsel
to the Company, dated the effective date of such registration statement (and, if such registration includes an underwritten public offering,
an opinion dated the date of the closing under any underwriting agreement related thereto), and (ii) a &#8220;cold comfort&#8221; letter
dated the effective date of such registration statement (and, if such registration includes an underwritten public offering, a letter
dated the date of the closing under the underwriting agreement) signed by the independent registered public accounting firm which has
issued a report on the Company&#8217;s financial statements included in such registration statement, in each case covering substantially
the same matters with respect to such registration statement (and the prospectus included therein) and, in the case of such accountants&#8217;
letter, with respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer&#8217;s
counsel and in accountants&#8217; letters delivered to underwriters in underwritten public offerings of securities. The Company shall
also deliver promptly to each Holder participating in the offering requesting the correspondence and memoranda described below and to
the managing underwriter, if any, copies of all correspondence between the Commission and the Company, its counsel or auditors and all
memoranda relating to discussions with the Commission or its staff with respect to the registration statement and permit each Holder
and underwriter to do such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the
registration statement as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation
shall include access to books, records and properties and opportunities to discuss the business of the Company with its officers and
independent auditors, all to such reasonable extent and at such reasonable times as any such Holder shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.4
<U>Underwriting Agreement</U>. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected
by any Holders whose Registrable Securities are being registered pursuant to this Section 5, which managing underwriter shall be reasonably
satisfactory to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and such
managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other terms as are customarily
contained in agreements of that type used by the managing underwriter. The Holders shall be parties to any underwriting agreement relating
to an underwritten sale of their Registrable Securities and may, at their option, require that any or all the representations, warranties
and covenants of the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such Holders. Such
Holders shall not be required to make any representations or warranties to or agreements with the Company or the underwriters except
as they may relate to such Holders, their Warrant Shares and their intended methods of distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.5
<U>Documents to be Delivered by Holder(s)</U>. Each of the Holder(s) participating in any of the foregoing offerings shall furnish to
the Company a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security
holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.6
<U>Damages</U>. Should the registration or the effectiveness thereof required by Sections 5.1 and 5.2 hereof be delayed by the Company
or the Company otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available
to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened
breach of such provisions or the continuation of any such breach, without the necessity of proving actual damages and without the necessity
of posting bond or other security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
    as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Loss,
    Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
    to it of the loss, theft, destruction or mutilation of this Warrant or any certificate relating to the Warrant Shares, and in case
    of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not
    include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company
    will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
    or stock certificate.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Saturdays,
    Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
    granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
    Day.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorized
    Shares</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jurisdiction</U>. All questions
    concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the
    provisions of the Underwriting Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restrictions</U>. The Holder acknowledges that the
    Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise,
    will have restrictions upon resale imposed by state and federal securities laws.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Nonwaiver and Expenses</U>. No course of dealing
    or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise
    prejudice the Holder&#8217;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Underwriting
    Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
    damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
    but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting
    any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices</U>. Any notice, request or other document
    required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions
    of the Underwriting Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Limitation
        of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
        Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
        Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the
        Company or by creditors of the Company.</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Remedies</U>. The Holder, in addition to being entitled
    to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under
    this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach
    by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance
    that a remedy at law would be adequate.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Successors and Assigns</U>. Subject to applicable
    securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the
    successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant
    are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder
    of Warrant Shares.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Amendment</U>. This Warrant may
    be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severability</U>. Wherever possible, each provision
    of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this
    Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition
    or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Headings</U>. The headings used in this Warrant
    are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><B>SAVE FOODS, <FONT STYLE="text-transform: uppercase">Inc</FONT>.</B></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TO:
SAVE FOODS, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">_________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> [ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    &nbsp;] in lawful money of the United States; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> [ &nbsp;] <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
    2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
    procedure set forth in subsection 2(c).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please register and issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. If the Warrant is being exercised via cash exercise, the undersigned is an &#8220;accredited investor&#8221;
as defined in Regulation D promulgated under the Securities Act of 1933, as amended</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
    OF HOLDER]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity: _______________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>: _________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory: ___________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory: ____________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    ________________________________________________________________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing warrant, execute<BR>
this form and supply required information.<BR>
Do not use this form to exercise the warrant.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________
    whose address is</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________.</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
______________, _______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&#8217;s
    Signature: _____________________________</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&#8217;s
    Address: _____________________________</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;_____________________________</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement
or any change whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper
evidence of authority to assign the foregoing Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT="Adobe Systems" STYLE="height: 105px; width: 105px"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 77%"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mwe.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
18, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HaPardes
134 (Meshek Sander)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neve
Yarek, Israel 4994500</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
    Foods, Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
    of Common Stock</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Save Foods, Inc. (the &ldquo;Company&rdquo;) in connection with the Underwriting Agreement, dated August 15,
2022 (the &ldquo;Agreement&rdquo;, which definition includes all listed exhibits and schedules thereto) entered into by and between the
Company and ThinkEquity LLC (the &ldquo;Underwriter&rdquo;), which provides for, among other things, the offer and sale by the Company
of 1,600,000 shares (the &ldquo;Firm Shares&rdquo;) of the Company&rsquo;s common stock, $0.0001 par value (the &ldquo;Common Stock&rdquo;),
and, at the option of the Underwriter, up to an additional 240,000 shares of Common Stock (the &ldquo;Option Shares, and, together with
the Firm Shares, the &ldquo;Shares&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the above capacity, we have reviewed (i) the registration statement on Form S-3 (Registration No. 333-266159) for the registration of
the Shares and other securities of the Company initially filed by the Company on July 15, 2022 with the Securities and Exchange Commission
(the &ldquo;Commission&rdquo;) and declared effective on July 22, 2022, pursuant to the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), including the documents filed by the Company pursuant to the Securities Exchange Act of 1934, as amended, and incorporated
by reference therein (the &ldquo;Incorporated Documents&rdquo;), and the information deemed to be a part of the registration statement
pursuant to Rule 430B under the Securities Act (the &ldquo;Registration Statement&rdquo;), (ii) the prospectus (the &ldquo;Base Prospectus&rdquo;),
which forms a part of the Registration Statement at the time it became effective with the Commission, (iii) the prospectus supplement,
dated August 15, 2022 (the &ldquo;Prospectus Supplement&rdquo; and, together with the Base Prospectus and the Incorporated Documents,
the &ldquo;Prospectus&rdquo;), relating to the offering of the Shares, (iv) an executed copy of the Agreement, (v) the Certificate of
Incorporation of the Company, as amended to date, (vi) the Amended and Restated By-laws of the Company, as amended to date, and (vii)
certain resolutions of the Board of Directors of the Company relating to the offering of the Shares (the &ldquo;Board Resolutions&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
practice conducted through McDermott Will &amp; Emery LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>One
Vanderbilt Avenue New York New York 10017 Telephone: +1 212 547 5400 Facsimile: +1 212 547 5444 www.mwe.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the examination outlined above, we have conferred with various officers of the Company and have ascertained or verified,
to our satisfaction, such additional facts as we deemed necessary or appropriate for the purposes of this opinion. In our examination,
we have assumed the authenticity of all documents submitted to us as originals, the conformity to the original documents of all documents
submitted to us as copies, the genuineness of all signatures on documents reviewed by us and the legal capacity of natural persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the foregoing, we are of the opinion that all corporate proceedings necessary for the authorization, issuance and delivery of the
Shares have been duly taken and, upon issuance pursuant to the terms of the Agreement and in accordance with the Board Resolutions, the
Shares will be validly issued, fully paid and nonassessable by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the references to our firm in the Prospectus Supplement and to the filing of this opinion by the Company as an exhibit
to the Registration Statement (as an exhibit to a Current Report on Form 8-K dated August 18, 2022 that is incorporated by reference
into the Registration Statement). In giving this consent, we do not hereby admit that we come within the category of persons whose consent
is required under Section 7 of the Securities Act or the rules and regulations of the Securities and Exchange Commission thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    McDermott Will &amp; Emery LLP</I></FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right; background-color: white"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;<IMG SRC="ex99-1_1.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Save
Foods Announces Pricing of Public Offering of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neve
Yarak, Israel &ndash; Aug. 15, 2022</B> &ndash; Save Foods, Inc. (Nasdaq: SVFD) (&#8220;Save Foods&#8221; or the &#8220;Company&#8221;),
an agri-food tech company specializing in eco crop protection that helps to reduce food waste and ensure food safety while reducing the
use of pesticides, today announced the pricing of a public offering of 1,600,000 shares of Common Stock at a public offering price of
$3.00 per share, for gross proceeds of $4.8 million, before deducting underwriting discounts and offering expenses. The offering is expected
to close on August 18, 2022, subject to satisfaction of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
underwriters have been granted a 45-day option to purchase up to 240,000 additional shares of Common Stock from Save Foods, exercisable
in whole or in part, solely to cover over-allotments, at the public offering price less the underwriting discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
is acting as sole book-running manager for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities will be offered and sold pursuant to a shelf registration statement on Form S-3 (File No. 333-266159), including a base prospectus,
filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on July 15, 2022, and declared effective on July 22, 2022.
The offering will be made only by means of a written prospectus. A prospectus supplement and accompanying prospectus describing the terms
of the offering will be filed with the SEC on its website at <U>www.sec.gov.</U> Copies of the prospectus supplement and the accompanying
prospectus relating to the offering may also be obtained, when available, from the offices of ThinkEquity, 17 State Street, 41<SUP>st
</SUP>Floor, New York, New York 10004, by telephone at (877) 436-3673 or by email at <U>prospectus@think-equity.com.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities
in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>About
Save Foods</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
Foods (Nasdaq: SVFD) is an innovative, dynamic company addressing two of the most significant challenges in the agri-food tech industry:
food waste and loss and food safety. We are dedicated to delivering integrated solutions for improved safety, freshness and quality,
every step of the way from field to fork. Collaborating closely with our customers, we develop new solutions that benefit the entire
supply chain and improve the safety and quality of life of both the workers and the consumers alike. Our initial applications are in
post-harvest treatments in fruit and vegetable packinghouses processing produce including citrus, avocado, pears, apples and mangos.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information visit our website: <U>https://savefoods.co/</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Forward-Looking
Statements</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains forward-looking statements within the meaning of the &#8220;safe harbor&#8221; provisions of the Private Securities
Litigation Reform Act of 1995 and other Federal securities laws. Words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221;
&#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates&#8221; and similar expressions or variations of such
words are intended to identify forward-looking statements. For example, we are using forward-looking statements in this press release
when we discuss the closing of the offering. Because such statements deal with future events and are based on our current expectations,
they are subject to various risks and uncertainties. Actual results, performance or achievements could differ materially from those described
in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are
subject to other risks and uncertainties, including market conditions and the satisfaction of all conditions to, and the closing of,
the offering, as well as those discussed under the heading &#8220;Risk Factors&#8221; in Save Foods&#8217; Annual Report on Form 10-K
filed with the SEC on March 31, 2022, Form 10-Q filed with the SEC on May 16, 2022 and August 15, 2022, and in any subsequent filings
with the SEC. Except as otherwise required by law, we undertake no obligation to publicly release any revisions to these forward-looking
statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References
and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference
into this press release. We are not responsible for the contents of third-party websites.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Contact:</B> &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>IR@savefoods.co
</U>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>US Investor Relations:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dave Gentry</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RedChip Companies Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-800-RED-CHIP (733-2447)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Or
407-491-4498</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SVFD@redchip.com
</U>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>German Investor Relations:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B> Dr Eva Reuter</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>e.reuter@dr-reuter.eu
</U>&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-1_1.jpg
<TEXT>
begin 644 ex99-1_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !1 6D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#L?&/CF_.J
MOH^B,R%'\MY8QEW?.-J^G/'KFLL^%_'1B^U&:Z,F-VW[7\__ *%6?IEU'H?Q
M#,VHJ=D5U(LC$=,Y&[]<U[?%-'<1++#(LD;C*NAR"/8UA%<]VV>'AZ7UV4Y5
M9NZ>R=K'F'A+Q-XF3Q#%HU_'+<!FQ(LZD/$.[9Z_GUKU*F^6GF>9L7?C;NQS
MCTS3JUC%I6N>IAJ,J,7&4G+U"BBBJ.@Y'X@^()-$T-8K:4QWETVU&4X*J.6(
M_0?C5KP1KIUWPY%),^ZZ@/E3$GDD=#^(Q^.:\X\1W,WC'QR+.T8&,.+>$]@H
MZM].I^E3>!=1E\/>+I-,NSL2=C;R ] X/RG\^/QK#G]_R/#CC9/&<WV'[OE_
M5_P/9:I:O;W%WI%U!:3O!<O&?*D0X(;MSV]*NT5N>W)<R:9Y5X"\4WX\1-IN
MJW<\PG!1//<L4D'0<],\CZXKU6O&_B!I<FA^*8]2M<HERWGHP_AD!^;]<'\:
M]5T34X]9T:UOX\8F0%@/X6Z$?@<UE3;5XL\W+ZDHRGAZCNXO\/Z_,OUY;\0_
M%-[%K<>FZ9=S0>0O[TPN5+.W../08_,UZ-JNH1:5I=S?3?<@C+8]3V'XG KR
M3P1ITOB/Q@^H7?SI"YN)2>A<G*C\^?P-%1O2*ZAF-23<</3>LG^']?D>K:#;
M7=IH=I#?3R3W03,KR-N.X\D9]LX_"N<^)6HWFFZ':R65U+;N]R%9HG*DC:QQ
MD5VE<#\6/^1?L_\ KZ'_ * U5/2#-L8N3"R47LO\CD+ ^.-4M%NK*YU*:%B0
M'%R<9'XU9_L_XA_W]4_\"3_\57;?#;_D38?^NK_SKKJB-.ZO<XZ& 52E&;J2
MU7<X?P-;>)X+ZZ.N-=&$Q@)Y\N_YL]N3VS7<445K%65CTZ%'V,.1-OU"O-_B
MK>7-JVEBWN)8@PE+!'*Y^[UQ7I%>8?%S[^D_27_V2HJ?"SGS)M8:5O+\S#L/
M#?B_4K&*\MIIFAE&Y";H#(^A-6/^$-\;?WY?_ L?_%5Z-X,_Y$_3/^N7]36[
M4JDFKG-2RRE.G&3E+5+J<EX%TC6M)M[Q=8=B9&4QAIM^,9SW..HKK:*X?XK^
M)Y?#/@F>2UD*7EXPMH6!Y7()9A]%!_$BMZ5-R:A$]*E25&FH+9=SF/B!\9TT
M>[FTGPXD5Q=QG;+=O\T<;=PH_B(]>GUKSF*Z^)WBI/MEO-KMQ$QR'A9XXS],
M87\JZ#X-> +779)?$&KPB:SMY/+MX'&5DD')9AW R..Y^E?0BJJ*%4 *!@ #
M@"O1G5IX=\D(W?5LNS9\MCQ3\1O!5S&;ZYU2)<\1WZM)&_L"V?T->Q> /BMI
M_C K87B)8ZOCB+=\DW^X3W_V3S]:[N]L;74;22TO;>.XMY!M>.50RD?0U\Y?
M$OX<S^"KV/6=&:7^RVD!5@QWVKYX!/7&>A_ \X)49TL3[LERRZ,-4?2M<3X]
M^)6F>"8E@*&[U.1-T=LK8"CLSGL/U/ZU6^%WC]?&.CFVO'5=7M% F'3S5Z"0
M#]#Z'ZBG^+?A5I'B_P 0PZO=W5S"ZJJ31Q8Q*HZ<G[I[5S0IQIU>6MLA]-#Q
MJX\=?$+QI>O%IT]]@_\ +#3$9 @]RO/XDTR1?BCX>C-Y*_B"&->6=I'D4?[P
MR1^=?3&EZ38:+8QV6FVD5M;(.$C7'XGU/N:N5N\;%:1@K"Y3Q'P+\;GGNHM.
M\5"-=Y"I?HNT _\ 31>@'N.G<=Z]M!# $$$'D$=Z\/\ C/\ #ZTMK)O$^DVZ
MPE7 O8HQA3N.!(!V.2 ?7.?7/2?!+Q/+K?A.33;J0O<:8PC5B>3$1\GY88?0
M"IKTX3I^VI:=T">MF=QXFD>'POJDD3LCK;2%64X(.T]#7C.BVGB+7Y)DT^YG
MD:( OFXVX!^IKV/Q7_R*>K?]>LG_ *":X/X2?\?VI_\ 7-/YFO,FKS2/)QU-
M5<53IMNS3V,]O"7CB!3(K7!(_N78S_Z%18>-_$?AV]%MJJRSHI^>*Y!#X]0Q
MY_/(KV2L;Q)X>M?$6ER6\R*)P"89<<HW^'J*;IM:Q94\NE37-AYM-=WN6M'U
MBSUS3TO;*3=&W!!ZH>X(]:OUXOX!U6?1?%0T^8E8KE_(D0GHX^Z?KGC\37M%
M5"7,CKP6)^L4N9[K1GF'CCQE?MJS:)H[O'L81R/%]]W/\(/48Z<<YK+'PZ\3
MW$0NY)H1<==CS$O^>,9_&J%W*WA[XC2W-W&66*\,I&.2K-D$?@<U[38ZA::E
M:I<V<Z30MT9#^A]#[5G%*;?,>;1I1QE6?MY.Z>BO:R/+O#MYXPTGQ%;:3.L[
MK(V&CN,LNSNP;L /0X^M>M445K&/+U/4PV'="+CS-KSZ''^+O MOXA<WEM(M
MO?@8+$?+)CIN]#[UY]_Q57@B?_EO!"6_WX7_ *?UKVN.ZMY9Y8(YXWFBQYD:
ML"R9Z9':GS0Q7$+PS1K)$XPR.,@CW%3*FGJMS"O@(59>TIOEEW1Q_A/Q];Z]
M*ME>(MM?$?+@_)(?;T/M79UX-XLT^+P_XNFAL'*)&RRQX/,9(!Q^!_I7NEK(
MTUI#*XPSHK$>Y%%.3=T^@L!B*E1RI5?BCU):YSQOK7]B>&IY$;%Q/^YB]03U
M/X#/XXKHZ\;\?ZG)KOBJ/3+7+I;MY"*/XI"?F_7 _"G4E:)ICZ_L:+MN]$:W
MPKT7+7.LRKT_<PY]>K'^0_$U2^)VD-8ZQ!J\ *I<\.5XQ(O?\1C\C7IFBZ9'
MH^CVMA%C$* $C^)NI/XG-5?%.CC7/#UU9@ R[=\/LXY'Y]/QJ7#W+&$L#_L?
MLE\2U^?]:#O#&L+KGA^UO<CS2NR4#LXX/^/XUKUY+\,-9-GJTVD3L52Y^9 >
MTB_XC^0KUJJA+FC<Z<%7]O14GOL_4YSQOHO]M>&IXT7-Q!^^BQU)'4?B,_CB
MN3^%>M;9+G1I6^]^^AR>XX8?E@_@:]/KQ3Q#;2^#O'2W=LI$7F"XB X!4GE?
MYCZ5,_=:D<N.3H5H8E>C]#H?BIK6V*VT:)N7_?38].BC^9_ 5T7@+1?['\-0
MF1<7%U^^DSU /W1^ _4FO.])AD\;>/&N)T/D-(9I%/.V->B_^@K^->V=*(>]
M)R#!+V]>>)>VR_K^MPK@?BQ_R+]G_P!?0_\ 0&KOJX'XL?\ (OV?_7T/_0&J
MJGPLZ<?_ +M/T_R.)T5?%YTU#I'V[['N.WRB=N>]:.SXA>NI_P#?1KM?AM_R
M)L/_ %U?^===41IW2=SBP^7\]*,O:25UW,?PL-2'AVU&K>9]M^;?YGWL;CC/
MX8K8HHK5*R/7A'DBHWO8*\P^+GW])^DO_LE>GUYA\7/OZ3])?_9*BK\+.+,_
M]UE\OS,+3/%'BRSTV"WLHY#;1KB,BV##&?7'-6_^$R\;?\\I?_ 0?_$UZ)X,
M_P"1/TS_ *Y?U-;M2H.VYST<%5E3BU6:NE^12TB>XN=&LI[M=MQ) C2@KMPQ
M SQVKR;]H0/_ &3HA'^K$\H;Z[5Q_6O9JX[XF^%W\5^"[FTMTW7L!%Q;CNS*
M#E?Q!(^N*[,-)0JQ;/52M&Q5^#K0M\,M+$.,JTHDQ_>\QNOX8KNZ^;OA+\0H
MO"5Y-HVL,T>G7$FX2$'_ $>7H<CT.!GTP/>OHV"XANH$GMYHYH7&5DC8,K#U
M!%7BZ4H5&WLQIZ$E5[^QMM3L)[&\A6:VG0I)&W1@:@U;6M-T*Q:\U2]AM8%_
MBD;&?8#J3["O/_#GQEL_$?C2/0X-+E2VG9E@N6?YB0"<LF. <'N:SA2J23E%
M;!<\FUO3-6^$_CZ.:TD8I&WFVLI^[-$>JM^'!'X^E?2/AKQ%9>*="M]5L&S'
M*,.A/S1N.JGW'^![U0\<^#K3QIX?DL)BL=RGSVTY',;_ .!Z$?U KY_\,>)M
M;^%?BJXLKZWD\C?LO+0G[P[.AZ9QR#T(_3M:6+IW7QK\1;,^IJ*R= \2Z1XF
ML5N])O8[A"!N4'#QGT9>H-:CR)%&TDCJB*,LS'  ]2:\YIIV91S?Q$:)?AWK
MQFQM^QN!G^\1A?UQ7E/[/8?^U];(_P!6((]WUW'']:9\8?B1::Q!_P (YHLX
MFM0X:ZN$/RR$=$4]P#R3Z@8KNO@YX4E\.>$3=7<9CO-183,C#!2,#Y ??DG_
M (%7?RNEA6I;R)W9UOBO_D4]6_Z]9/\ T$UP?PD_X_M3_P"N:?S-=YXK_P"1
M3U;_ *]9/_037!_"3_C^U/\ ZYI_,UY4OC1YN)_WZEZ/]3U2BBN>\5^*;7PY
MISGS%>]=2(80<G/]XCL!^M:-I*[/1J5(TXN<W9(\LO2)/B2_V;'.I#;CU\S_
M !KW2O'/AUHTVJ^(CJDX)@M6+L[?Q2'H/Z_@/6O8ZSI+1L\W*HODG4?VF<[X
MH\(67B6(,Y\B\082=1GCT8=Q7F5YX?\ $_@Z9KJ!I5B7K/;,2N/]H>GU&*]D
M34[&34)-/2ZB-W&-S0[OF ^E6R 001D'J*<H*6IM7P-*N^>+M+NOU_JYYYX3
M^(WV^XCL-85(YG.V.X485CZ,.Q]QQ]*]#KP_X@:=::7XJ=+)519(UE:->B,<
MY ].@/XU:_X2KQ1_=F_6HC4:TD<=#,)T7*E7]YQ>Z)]<\+>)="UB75-/EGN=
M[L_GP\OR<G<H_P#U5&/B)XI1/LS11&;IN,'SY^G3]*]CHP,YQS5>SMLSH>7.
M,FZ-1Q3Z;GD'ASP9JNO:N-3UM)8[<OYDAF&'F/I@]O?TZ5Z^!@8'2BBKC%1.
MK#86&'BU'5O=F7XBU0Z-H%W?*"9$3$8QGYCP/PR:\V^&VC2:AK\NJW*L4MOF
M!;^*1NGY<G\J]=ZT  =!BDXW:9-;"^UK1J2>D>GF%%%%6=9XQXVTR?P_XP74
M+-2B3.+F)@.%?.6'Y\_0BO7-,OEU+2[:]12HFC#[3U!/45:(!Z@&EJ(QY6V<
ME#"^QJ3E%Z2Z=@KCOB/HG]J>'_M42;KBS.\8')0_>'\C^%=C1525U8VK4E6I
MNG+J<5\-=$.G:$U],FV>\.X9'(0=/SY/Y5VM%%$596"A25&FJ<>@5P_Q0M;B
M[T&T6W@EF9;D$B-"V!M;TKN**)*ZL%>DJU-TV[7/#]+UGQ=HUBMG8PW,<"DL
M%-H&Y/N5JY_PEWCG^[<?^ 2__$U[)16?LWW.".75(JRK2M_7F</X&UKQ#JE[
M=1ZPDGE)&&0O (_FSZ@#WKN***TBK*QW4*;IPY92<O-A7GOQ.TG4-3.FFQLY
MK@1B0/Y2%MN=N,X^AKT*BE*/,K!B*"KTW3;M<Q_"EM-9^%]/M[B)HI4CPR,,
M$<GK6Q1132LK%TX*$5%= HHHIEGF'C_X06?B>XDU/294L=3?F16'[J8^IQ]U
MO<=?3O7EA\!_$CP[(\5E;:C&A/WK&Y^5O?Y6_F*^HJ*ZZ>,J0CRO5>8G%'S%
M9_"OQYXCO!)J44D(/#7&H3Y('TR6/Y5[/X&^&FD>"D^T*?M>ILNU[J1<;?4(
M/X1^I]:[:BIJXNI47+LO($D@KE?&G@+2/&UFJ7BF&\C&(;N,#>GL?[R^Q_#%
M=516$92@^:+U&?,NI?"/QMX>O#+I:&[53\EQ93;'Q]"01^&:K-X,^)>N%;:[
MMM6FCSTO+DA![_,U?4=%=BQ]3JE<GE/(O OP5M]'NHM3\0RQ7EU&=T=K&,Q(
M>Q8G[Q'IT^M>NT45RU:LZKO)C2L9GB."6Z\-:E! ADEDMG5$7J21TKQ[3-.\
M8:,\CZ?8ZA T@ <K >0/J*]THK"4.9W./$X)5YJ?,TUV/&VN/B%<+Y975 #W
M$13]0!4^D_#?5]3N1<:S,;>-CE]S[Y6_G^9_*O7:*GV2ZLQ660;O4DY>K*NG
M:=:Z38QV=G$(X8QP!U)]2>YJU116IZ22BK+8\K\3^ M8BU6;5-)FDN3)(9,!
M]LJ$G/![_AS5!/$OCNVB-L8[PL. SVF7'XE>:]CHK-T];IV/.EERYG*E-QOV
M/(]!\":MK6J#4->$D4);?)YI_>2^V.H'U_"O5_LMO_SPB_[X%2T548*)TX;"
M4Z$6HZM[MA1115'2%%%% !1110 4444 %%%% 'EDGBSQC<-XGO;*ZT:.ST2[
MEB\FYB8-(B<_>#=2./K77V_C*Q7P+:^*-1!M8)8$D:,#<=QXVKZY/2N2O_@]
M:ZH/$%Q=S1?VC?7CW-G<+N_<@G(1ES@CUX[UT^O^$7\2^!DT*\E@MKE4C(DM
MH_W22)TPI_A]O0UUS=%V2[Z^EE]^HM2;0?&=EKFHR::]EJ&FWZ1>>+:_A\MW
MCSC<O)R,UD>)/B19Z<=7LK"TU&YN;&%Q-=V]MYD-K)M.W><^O7@]_>G^#?!5
MQH6IRWU_;Z(LHC\N)M/MW5NO)+,QZ^@&*IW_ (&\0PWNO1Z%K%E!IVN,\ERE
MS 7DB=@0VP@XYSWZ4E&CS^7]7Z!J;6E>*XK7X<V'B/7;D#=:I),ZIR[-V"CN
M2>E3:#XTLM<U)]->QU#3;X1>>EO?P>6TD><;EY.15"\\!C4OAI;>%+J["300
MQJMQ&N0'3H<'J*A\'>";G0M4DOM0M]$618O+B:PMW5_<EF8]1V Q2:I.,GUN
M[?H&IFV/B[6=9^*]SI$9O[/3+%@C0BQ5A(=I):5R<HI(^4CJ,5M>#=<67P;>
M:I<ZG=ZE';2SL\T\"QOM3DJ%4D'&/7OVJ[I/AN?3O&NOZ[)<1O#J2P+'&H.Y
M/+7!S]:I^'?!]UHW@C4="ENH9)KHW!650=J^8"!GOQ1.5-JR\O\ @AJ5M-^*
MFBZE?:? MEJEO!?N(K:[N+;9"\G38&SR<\<<9J]KFIM;>//#E@-4NK<70F)M
M8X%:.?:N?F8G*X]@?PK,D\ 7C^&?"FE?;(!)HM[%<ROM.) A)(7WY[UL:QX9
MGU+QMX?UV.XC2'3%F$D; [GWK@8H?LE+W?/_ ('3J&I%KWC[3]!UHZ.=/U.^
MU#R!<+#96_F%E)(]>V#6CI'BK2M9\-'7X)FCL51VE:9=K1;,[@P]L563PW.O
MQ%E\2^?'Y#Z:+/R<'=NW[LYZ8JAH7@_^QO NI:%J,OVJ.Y-PS_9E.XJX/"@_
MQ?UJ6J7*K;Z?\'[@U*T'Q5TB:2SWZ9K,$-].D%G<2VNV.<L<95L]/UKNZ\$M
MK37-9O?#&C076JWEIIM]%+Y5UI1MA;Q1GK(Y)RP'R@#W]J][IXBG&#7+_78$
MSSOQ3XKUJS\>QZ#8ZGI&G6QT\71GU%3@MO*[0=P[8_(UOQ:])HO@R76]<O;6
M_6$%VFTU<HZ[L#;D\]?6JNH^![?5_'Z:]J,5G=V*Z?\ 91:W$0?Y]Y;?R,="
M15[Q'X8CU3P5>>'M,6WL4EC"1*J;8T^8-T'X_G0W3:C'TO\ KYAJ.TKQ=I^J
M:!<ZX8KJST^#+>;=Q>7O0*&WJ.Z\\>N*I:-\0--UC4K:Q:QU*Q:\4O927MOY
M:72@9.PY/;GG'%:-YX=BU+P8?#UW(0CV:VS21CH0H 8#ZC-<IX3^'5UH>KVM
MQ?QZ'+%9H1%-;VSK.[8P&8EL _3K1%4G&3>_0-3<U;QW9Z9KDNCP:7JNIW<"
M+)<+86XD\I6&1G)&>.>*I_$3Q1>^&M+T6^M'>))]2ABN5\H.YB(8LH![\=N:
MH>,_ .I^)M8DN;=M%B1U54NG@D6Z@P!R&1@&YSC/3I6UXD\)W.M:=X?M8[X%
M]+OK>YDEG!+3",$'I_$<YIQ5).+^_P"X-2?PWXTL?$E[=V*6=_8WUJ \EM?0
M^6^P]& R>.GYBLO5/BCI.EZA?V9TW5[EM/DV7<EO;!DB']XMG@?X&M2V\-SP
M?$*^\1F>,P7%BELL0!W A@<D],<51'@VZ%OXQC^U0YUTMY)VG]UF,K\WKU[4
MDJ/-=[:?\'[@U-J_\3Z5IWAM=?GN/] >-)(W526D#8VA1U).1Q530?&5GKFH
MRZ:]CJ&G7Z1><+:_A\MWCSC>O)R,U1U3P*-7^'-GX8N+H)-:P0JEPBY421J!
MG!Z@\\>]0^#?!5QH6I37U_;Z*LWE^7$VGP.C 9Y)9F/7TQ2Y:7(]=?ZL&I:7
MQ_93Z[-I=CI6K7PM[C[-<75M;AHHI,X(8YS@'J<<5:\0^,K/0-0MM.^PW^H:
MA<(94MK*(.^P'!8Y(&.OY5RVK_#G5M5\4'44N-(LE^U"87EI#)'=[0?NG#;&
M.."2*UO'/A"^\3S0-;0Z++''&4_T^&0R(2?O(Z,".W'2JY:/-'73J&IUNGWG
M]H6$%W]GN+?S5#>3<)LD3V9>QJS63X9TB?0?#EEIES>R7LUO'M:>3JW)/Y#.
M![ 5K5SRM=VV&%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !I &D# 2(  A$! Q$!_\0
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M>"#T-.KE/L3A/BC_ ,@>Q_Z^#_Z":X/PO_R-.F?]?*?SKO/BC_R!['_KX/\
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D(OR*?9?\<UUM%2ZC>ATT,KP]*7._>EW>H4445!Z(4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>svfd-20220818.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaWO+bP9z5Z8aekhvWBwbdnaHyEoudIHRiZtwMYWYfoC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:SVFD="http://savefoods.co/20220818" elementFormDefault="qualified" targetNamespace="http://savefoods.co/20220818">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://savefoods.co/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="svfd-20220818_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="svfd-20220818_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>svfd-20220818_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>svfd-20220818_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://savefoods.co/role/Cover" xlink:href="svfd-20220818.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://savefoods.co/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139886238796080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 18, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 18,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SAVE
FOODS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001789192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-4684680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">HaPardes
134 (Meshek Sander)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Neve
Yarak<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">4994500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(347)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">468
9583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
                                            Stock, Par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SVFD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="svfd-20220818.xsd" xlink:type="simple"/>
    <context id="From2022-08-18to2022-08-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789192</identifier>
        </entity>
        <period>
            <startDate>2022-08-18</startDate>
            <endDate>2022-08-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-08-18to2022-08-18">0001789192</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-08-18to2022-08-18">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-08-18to2022-08-18">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-08-18to2022-08-18">2022-08-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-08-18to2022-08-18">SAVE FOODS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-08-18to2022-08-18">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-08-18to2022-08-18">001-40403</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-08-18to2022-08-18">26-4684680</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-08-18to2022-08-18">HaPardes 134 (Meshek Sander)</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-08-18to2022-08-18">Neve Yarak</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2022-08-18to2022-08-18">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2022-08-18to2022-08-18">4994500</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-08-18to2022-08-18">(347)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-08-18to2022-08-18">468 9583</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-08-18to2022-08-18">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-08-18to2022-08-18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-08-18to2022-08-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-08-18to2022-08-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-08-18to2022-08-18">Common                                             Stock, Par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-08-18to2022-08-18">SVFD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-08-18to2022-08-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-08-18to2022-08-18">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-08-18to2022-08-18">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M!7A^*:7^V#%+[_R7D_X_4$L#!!0    ( $]:$E6?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M 5!+ 0(4 Q0    ( $]:$E4'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 3UH25649[ZKO    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ 3UH259E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " !/6A)5@Y4C@7,$  !%$0  &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ 3UH259^@&_"Q @  X@P   T              ( !MPP  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " !/6A)5EXJ[',     3 @  "P
M@ &3#P  7W)E;',O+G)E;'-02P$"% ,4    " !/6A)5JL0B%C,!   B @
M#P              @ %\$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M3UH2520>FZ*M    ^ $  !H              ( !W!$  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 3UH25660>9(9 0  SP,  !,
M             ( !P1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  "Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://savefoods.co/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex1-1.htm</File>
    <File>ex4-1.htm</File>
    <File>ex5-1.htm</File>
    <File>ex99-1.htm</File>
    <File>svfd-20220818.xsd</File>
    <File>svfd-20220818_lab.xml</File>
    <File>svfd-20220818_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "svfd-20220818_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "svfd-20220818_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "svfd-20220818.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "SVFD",
   "nsuri": "http://savefoods.co/20220818",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-08-18to2022-08-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://savefoods.co/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-08-18to2022-08-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://savefoods.co/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001493152-22-023422-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-023422-xbrl.zip
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M%V55]]+]O>_W88"8=F!,.L+RJM8.F(SY=2,VD%?DM/B<@2?"M&SB_6YG]/)
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MF.U@%\O!+YO50BJ 0H/L9%D9/V1'0D4\/ANT#)'*2O+0W&U1%,>W323$/%!
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MP82FQRXLF?5E;?MC_*[F&FS(RSM?Y<B$469-;%M/>M>6) 95-*3K7,&U_O?
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M[>KV)OL42_G@L"9O5.O@]^S>;=6XCKQM1D<9**1R+I4/V2',S3YG"Z%U038
M8>ZU%1L=SY1@+IF4(XDKHUQ5QAGK:H$.'%,YEW9R*EO"U@7YIZ3(54>LM%J@
M S#5B&R<"M9%Q+VZ%O@0X[<5BH<0=ES6@:@[_)?7S<R0TQ)^2)AI^_QY7FA
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M[??V-7>6@/#A=]+GR4EP <%3"HXKGPTF/2&R_9(@#I(EIYPF$@TQKLX=:I+
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MF I.J5!., <56Z C7V?<8+D\F$E?;B8=[HL;AN'#@;1>_#U:+)^^93*HK>F
MUM+K'A,FXZQIU'10<A6*%7JWQD7&1V%):(8-]PVZ'*2.5XN\MLGF:S/ZQCC<
M.WP0Z.[.I+%>(@HK$"Z"9><R/"F&TOA2?I,@H\9<,.&OH[,YS[,:Q"2F+[W
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M\C&3]:F!#TI5G%&\NM1 Y"9KA=\+?[PPY<!:A<P9RH%0B/14O5_A%QH[@,+
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MN'-[4#$VF]V%(NCIB>2-XNZ4#@:XWB2W6[)V"0UNH*NZ@1X.;J ;<0,]&-Q
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MLXLL:![X:\_]^]<_?%=^YP-.HZ-D(*=;FQ;Y%S9N5D0@/!.FDHU50>\ B7S
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MU']6513\%%5)J0_][5(5$<7WM01 S0#Q8DD43!,RC@>I<-L+O'GZ. ;Z.%F
M6%@%OZFD) J)D@)^JO7#9SF("_S#Z)&#A-@F"G@ %/"Z+"(%%X,J5%;.*Y7
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M="FQ2:E7W@"/4'L)^B^T]P[97OX%'03^%WV2EJBO/.%CHO2;VG.@^(V;XK]
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M3EGDIGW%95I6:$P"+$A!))BNQAWA>(2(*YA(7S;+6W01>>W6ZB1>AKHI*$.
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M1X.*UZ+BJF5O2!&/J0.";^C*F11]BJ)0S1+AVLE>9A7L?>?1H+&,YH(5(M^
M3X-?X P>(IP:6A"323+I)_U1?-A8*5OD3^LY7::I:#FJ@8(WM8S.E[_?ZQC
ME#9KAH8HZ[)+/HRF"-X[C3(4*9?':$;';DE*??1X8EWOH=][!RJ9RIGDX_)@
M9YIAAI8IJ;@D,_-9LDHB9XYKEZC\EE#^%KE_@WF636NP1)PNQB_#^6'$*_XX
M7U9F?W4^7X2KO8&*((-HGL,&\:O)G9/(SR1ETOY0W.AGOG?GKATO-):L44@4
M/%GP&[!$S=(57">V5#5XNI5N*C/G+('_2JU5*51/9?E2#MUQ?$GK7_I:7M<$
MFHU%A!J+BJ:#1.#K#HR_5R]KD\"7)-Z,2G%DEQW=3,>Q[$Z"FW_R,<LO4Q6?
M\TT>8;!8JFCAJ^PN&Z,#2_X0;%"2'/0D,"#@.]%B%M:X((R%TK8M:_-MMD:X
M>EWL=L63J=_ 6DV4!%LRY[ "&=LS8OW([1&)QN>]5U:1A 8Y*C'A79I/UXZ[
M;6-'__5!C\&.=GPEMF_8A<(CY%@3C4A7(S:UBA\#CN3??D?V$-A#83LUA[ME
M:U0?3?$TU<?&L;MG&W+"&W)?V[.>%X]D&FFBEHY!SZK5V7+6J]):M].,OX$=
MWN^1(=[-@.1X@3Y[6*A=*@K#.GI>KJ6&.QJE)15^&]/-.J94?NYZIHQ;1EG&
M5Y+LI"M%CDS#&]!YT<1-K7C6'[Y8.*6XL)W(JORKQ]J$I[722/P89@82#$'G
M8[0NV.DFH"PNQ.^#O4>OAL'@7\-_X\^)@HE83QX>/\F&J+!)MF\61(_BBR[$
M7Z,F7"7W]M;C6]Y#<%)8UG]^Z4'<:GRN9-FL\_(L&"1#4A28$P]JJ5],QR9S
MXIRI%#C3-HUI2Q&GUP<F#/^$^56-UQ%T[F!G",>CF@4F1H5&OG4^762S#99$
M0S&#.1J#0#Y-_^8G>0^8>P0]%N\M,A^?_BKWP8:TCKS-A:*"%OB@Z'W&GMK,
M["R'%VC=/[ L9"P+7 :$SOYA>WLP'@Y^>$(!E1,+L3[ZY=2#L%HBGJF"OX'J
M=PI!T^BR'&HN#E?H$!:^>^59E"^V_-[*FP6/EV0<^+/&DK1.76,=*+GM1BQJ
MOBI]F^$];"8X!"<2 ?(^:6T)HGUA46ZXKG7AAM=O*Y2G;4W:)YJE:9]M]ULK
M9KXY>RL^O.)PLBC7C:\VFY\PD?6]ZVG;K\[F^C6),#XCW_UXD^^^A7SWXTV^
M^ZODNS=6]\;J_@2K^Y6VND5\A]5[?:UNBLI[]NX["]7T0MRE!-XDJ4J6W7.\
M:]LOO#7=N'=ILVYDW6RK-5^JP;_NM-+K3)&1HWZ9+U.LYB#&(K(UB3E?>2 B
M)R3;0B9?&>[FQH>G0D&)<IA'7B*ILQ^@Q<BL_4 158; -&IB.+8>MO=QOU,=
M*YB[#IN1=LRY6:HM<E.[H_V&$I9RS@B=P"=T9K7;MKK!4SX&OWKPDT%HU<O\
M6Q+7G$^HHH]*AQ4<M-D$/A--X._P@V12UG+?"%Y!S]M)@1BPP2Q/R2M?P'?S
M^+HOZA1W!<.6;#8'S58^1H;@(QAHHJ06(N_W:&#X\T5>,JN[1@SQ*QSN=818
M;1*4]^K4?O>RAB,C)!L!R8(N')D.>-;PGV%'JCQ:POBB2E!E=D=?)"U7A(F%
MP<9<E]WWU7O-WL^-%G,F_!>%Q<^B*[\YIGW3S.V;>R=V%%]8GZ^UU9]LB6S8
M<D5 ]$W+_SV:^#Z$I E.G& E;9LE8R&/%IG$Y/R$&)DGE<GK@96/580&28(X
M?0.=%: %DM:##21 ?$RQ@-&%D#L/&&(0X-(7C ']RO84'T<IV6GZVV2OG6DG
MZ$"179+#=)PA_9@9JV[T@<^4#^$K$$J/*/,( ?G!/I+JQPFX(\S,'PPL".O@
MP]Z^WX;,+T*0XES)<[+=.4D6XDN1R2H/I0K"A%R?P=Z0TV24)<H$6(O($S8:
MI4L5@1*)U6R!MVAEII"<N<Q6(_LK*"F]G*FCD,*V VP)2\.SSV6:KX:M .P"
MP3S)>:+!EO)(OZ(2ER-?5KK %WNJ8/E"\2B?/L*/LTQN3S8WG678MW1#,YDG
MB]FNPT01DDR0;R(:]V7QTL7>%_5FD9/#?<F<-E54&#!D\YO@^)=2N&!:1<3.
MJ8MTV[L)V36.O2_5!+)'S!YF$*'^G$E'$]H(J;E\J%3M)(2F_J+;X\^;.">G
M:YXWY;0SM3UE=HQ;#&.+(_SI%8E;LICR.:]+7&NUBDU5UDJ!6!!]MKKK8P:F
M%)RW1T=_-'^I_39K?M>2!EY<@BM<^^!U*7%K9;K0RVZ1BG[LC,KUN1OB:H2>
M6T0E2]-\ES>TK>"P]81/0+F,E9.Q1W,:51I/6TUQ.]2A1E!FJ:NMC$7Y<45T
MK28J)$\QA;&E0;Y(,BXP-YUI\LERSEPA>>:UETDJ=WYIB6OC$34CVD2!U#'N
M!8.K%7!\K1";8?-2[JTH H'=_7Q!]$"-2K38!;IKX/4+C=[5':A8#E33RU)W
M8YRZ8 TN-"=.(54O#U^AI_S%O>E:L32U<:"6RK-I4LPC#<=<<2,,G%-A2G[H
M!JK!.'-]?NK/CTI/F>AWM49+Y'0Y\R7?<N\W/$GGS*!8>PA%,MN\0XE3LB!.
ML++C=L/[N_6*:[NB$#.T,QRR1=4Z*J_A$2Z0V$IX6W$PBR\8J^9IB]+96'#O
MLC(/3$6C[HR$-X3PZ:%AT?XJ^,DDG^.BS.3I4ZEW,: P-DE88.)C@><()V09
M"B.05[S47645\LE81%=SQ^ZK:>^:;AODA;$=FR$\XLY@6T?%0X[845CM3U5Z
M%6@UQ@5S9JDT+NS RL3#P44R-.?.JE9WOSGS$VHJ31HVOL_H65,7%B5I:7AM
MI$C&O20\6[@M;LC*RQR::,7%6BIL6NN3N7B5-M<J$=\%6$17OH"AL4EP:6@W
MI E,.K-%Q=$\.A<J#$+_(<()]'^45E=LG:@(YNYO.^'V]G;;H;=ZVK,^'*8:
M#<TR4+!&N<5*S%;+W,%-_[>=;:KA<.<-D6FX6E(=_+?=YD?RS&Z0:3*M9CZ:
MBTP8&D?+%(W!QN-*K\FD6*JAG9WF,ZY;6>?8KEA? =BU79KX66L!@""R&^%W
MDP0;DWFKL<;IET=?VO>_"?[KR0;_=0OXKR<;_-<&_[6)**Y!1+$CI(A/,&G&
MEH#B80T+X/@CS5)\KN!J&"#&C107R=SZD5O%3&:^+=.O@Q"\&(P\KTHXFN)&
M:YJV5]ANI>E07F9G(%#HZF03;6<)U4K3)]*5SOCC968CJ0VWG/H(HU%0HV@)
M)8(#+_?=%YY?CT9-/-*2X!UX0U*$2C ;]I$=%_J:GLJ'>@XW@+$[LU2)JS-/
MT(CFO@LGI!4<]5AW$T%#<-:E/6ER8Y_1\6Y9#L_%!0]7_,7KW,',C^"G3ML@
MTG <42,GP?<1GN/(=:@(!QR:^9CEEPK>0C^TH=5ZT:WKRA>J6A89^<^U<=;9
M,]T">N;#GFGY5%P+9@L)%+A5$[HZL.N[@;/)*^$Y;TR89&5$EF(-+90PK>Z6
MQNZ@&,A.*FUR\"6U9)>9Y6A"\]'Z/+_GB'/SV>JJT(M@1,@!ADVRF5\ Q;AL
M7I;NG:9G$D2%B22IAIMKXR[HHLVU<6>6*KFPMP;J$)65DGD 1?)J>?7HD#C/
M7L-5@?QE<-KQ@:"V1''?(,L/3\ H@DLS)*8B&ZR&-<>+T3O!TT^^LS0DX),N
M+4IY>]JZ01NX\NH2DF4G!&>"U3;KZ2>6P$@N\H\U*WW ]%-84<QB"!$Q#2J:
M:/9DDPD>ZE8--37.C\9P >9!G,RQ88<*=<2]SI7L7/L8U8<-44XC :$:9Z@E
MW]Z>OFED?[']$Z(1,#;):2*JQ5WHHD\;@HV<'"IO1B]=:D*A7F9;+G2$,V L
M6>+&+7N!699L?!XY2$C6P9_#MAEELC*S4,S#8^\[R2"8:9^8YE>E?L>P3E?8
MPE)M_3/U)Q)CE\'@:NC(ZW%ZS)%H;9%>X01B,7UU,P"^.UN7D9_$:#?X$L+6
M9F+2&9O%4CE6G$82<L[![M#&J7FB$/=O=D*IT&'$" UR8:'T!3Y%!^$M.1?G
MN.F=D:T:Y].&V! 93+YHTKJ$ MC0-D^2$72%16KG^R(T#$S%!>QM^&?G).(J
M2B]F;\.BC)B$F.49&2T#C^C/B9F;;]139L9RI&/=;7Q;T;K.L"VTL/$/SO2Q
M'+/()Z2K6*]C^\(TD3)ZTE%VC6WY]Y6S,@["8 O9XN +$3Q#&=VM$3"&"9 %
M%2^!I)645M1^QF!L?]OA! YJ_ISHZ_3MU,B#9TAGJN;4A\[-OK9/E)BB^!#J
MT*AM;<ZUTNMOND-)S&T4,Q1^!NX,0:I(=EH[LP(QXV83!U?AZ[(ZTV7DJ5W.
M;7EL@Y)*DVRX=]P+3&-FEH\V1L/;P.!(Q4B2&E[CYK^M)M"S+6.2A2"D 6EQ
MB9PU !ABW-L<V5QC[CAEE9<ED8,Z$&XY,S0< FJ9,%S37Z'+7+D&!AXI*K@P
MQ'S48L E](-3DD:70C>LJ(5,X+@P/K;#(,5"Y!U1$RS;0.D9E#3!;!VRG3(F
M,(N_IZ?^0>T,"!(!!VO:V+!MH*RIM;?D7,K!,_/1=N9;JJ@<W>:H^7K'2*ZD
M,MR":Y-J^\99M:>;K-HM9-6>;K)JFZS:)JOV[7U]Q]6'D_FZ8)<.6_^9R.;I
MI$@6[+;#1Z;V(Z7Y"+9L7UA"?[RJFY\S9HL42M+-Y#H,#I;&20H%>Z:+H'ZF
MVWZIX4FR?>N HGWF1&.D-7U++_'G&!ED$)#5*U21VHL@HTN*ABU1:LT:HE<P
MK[:1OYU-FC^I/R-N7.*4,+2@U! #B"6J"!.5BSN#'2,-$VB*-O'1NW 0-_'1
M.[-4%TY6;1].V#E^^(R0G^@.CZ3YED0ZG7Q'%PH7VYR8PI0)/;'F8&G<)L=3
MN+D;!3C%.XS^M+!U\%0HR4Y\_(QZ;_IG#2!I'7% V?NI5J]F<*:SF-=/S--0
M#K8^;LT3U2^"U94EHJ3YMP7]6:+C(A7D,3@O$\:L6T^9O]Y,_K7G_>3]\%/T
M?O G;=CKW)<X$HDJPQ"AQ^!!0G78R<N'76)TT@!%!%_1#/]@!1E.I5/9LD<D
M^73+<.<5:M)B6J]0=Y<:I66SH9SK^N,LB@O(M$,8TM.!>7ZH]+\4[#1?O<LY
M_#]VO4DDO Y^^7P,'B2&W\UN;6Y29V]6NEO,62O<E]#4?A2?VML9?Y6RFC#=
MCV(BWLRQX[#0;;9W+1"XC""UZ6%RR#J+\KBA,:^Q*M$=X?Z&DU3Z[4SR8J&S
MIN+H4^Q&VAN:KH5#([?4/KC"DUE1Y%DRN08'M+G)[\+UL+G)[\Q27;@ F?TT
MUPKD%?;/:M8C$_($8_G,6XHN08E!-BEAD:Y;A6G<DC!8A M,Y2H%%PGOF=+
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M3W?YDEJ>KKM>[O&-Z7P'ML[=EG6SK=94UOG=T9RG"O:!EU[[@.J/^B'GX)R
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M=C7[_:OC@]_P\OC^S=DO;U_^?U!+ P04    " !/6A)5U+OHS^ )  ##.
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M1=5**IFY,9K)X/+T<R+C:S88'"_QEXLFHDP+&8MAI.:2^)JHJ,XX4MJ4*>(
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M6<+3.Y-[ +_ EG?&C1"C.X/4 1W3D>6X*[M**)!KZ@TZ2.^DI-F$:UG@08B
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MM;[+/F7>S=@9-_:Y/_6]_M0R=Y!NN>\:_6>N_U==^H_>_P)02P,$%     @
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M6V3UULOBK<OB,]K)5*:U_J1Z-GO+0*.!?OB_K($$)T40C4G5JB:S\2F;W"8
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M/.8I<CI#N&!C9DJ*A7XV'Z91#] (0QCP-R"Y[2+R%,*="GYLWLNZ,L8F[P>
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M@3%4A.FR<^3KSFYP[Z<MOG&_W#M8[9;_ 5!+ 0(4 Q0    ( $]:$E70D7J
MK=D  $X!!@ )              "  0    !E>#$M,2YH=&U02P$"% ,4
M" !/6A)5?9X'GQM>  "7F0( "0              @ '4V0  97@T+3$N:'1M
M4$L! A0#%     @ 3UH25=2[Z,_@"0  PS@   D              ( !%C@!
M &5X-2TQ+FAT;5!+ 0(4 Q0    ( $]:$E4C($WC!PP  -@[   *
M      "  1U" 0!E>#DY+3$N:'1M4$L! A0#%     @ 3UH25<",MF[[%P
MB[D   L              ( !3$X! &9O<FTX+6LN:'1M4$L! A0#%     @
M3UH2525D"$E0 P  N0P  !$              ( !<&8! '-V9F0M,C R,C X
M,3@N>'-D4$L! A0#%     @ 3UH257$[IM#^"@  @(8  !4
M ( ![VD! '-V9F0M,C R,C X,3A?;&%B+GAM;%!+ 0(4 Q0    ( $]:$E6-
M[MN35P<  -57   5              "  2!U 0!S=F9D+3(P,C(P.#$X7W!R
;92YX;6Q02P4&      @ " #; 0  JGP!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
